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Abstract
Bacillus anthracis (Ba) and human infection-associated Bacillus cereus (Bc) strains Bc
G9241 and Bc 03BB87 have secondary cell wall polysaccharides (SCWPs) comprising an
aminoglycosyl trisaccharide repeat:!4)-β-D-ManpNAc-(1!4)-β-D-GlcpNAc-(1!6)-α-D-
GlcpNAc-(1!, substituted at GlcNAc residues with both α- and β-Galp. In Bc G9241 and Bc
03BB87, an additional α-Galp is attached to O-3 of ManNAc. Using NMR spectroscopy,
mass spectrometry and immunochemical methods, we compared these structures to
SCWPs from Bc biovar anthracis strains isolated from great apes displaying “anthrax-like”
symptoms in Cameroon (Bc CA) and Coˆte d’Ivoire (Bc CI). The SCWPs of Bc CA/CI con-
tained the identical HexNAc trisaccharide backbone and Gal modifications found in Ba,
together with the α-Gal-(1!3) substitution observed previously at ManNAc residues only in
Bc G9241/03BB87. Interestingly, the great ape derived strains displayed a unique α-Gal-
(1!3)-α-Gal-(1!3) disaccharide substitution at some ManNAc residues, a modification not
found in any previously examined Ba or Bc strain. Immuno-analysis with specific polyclonal
anti-Ba SCWP antiserum demonstrated a reactivity hierarchy: high reactivity with SCWPs
from Ba 7702 and Ba Sterne 34F2, and Bc G9241 and Bc 03BB87; intermediate reactivity
with SCWPs from Bc CI/CA; and low reactivity with the SCWPs from structurally distinct Ba
CDC684 (a unique strain producing an SCWP lacking all Gal substitutions) and non-infec-
tion-associated Bc ATCC10987 and Bc 14579 SCWPs. Ba-specific monoclonal antibody
EAII-6G6-2-3 demonstrated a 10–20 fold reduced reactivity to Bc G9241 and Bc 03BB87
SCWPs compared to Ba 7702/34F2, and low/undetectable reactivity to SCWPs from Bc CI,
Bc CA, Ba CDC684, and non-infection-associated Bc strains. Our data indicate that the Hex-
NAc motif is conserved among infection-associated Ba and Bc isolates (regardless of human
or great ape origin), and that the number, positions and structures of Gal substitutions confer
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unique antigenic properties. The conservation of this structural motif could open a new diag-
nostic route in detection of pathogenic Bc strains.
Introduction
Bacillus anthracis is a Gram-positive, spore forming bacterium that causes anthrax. It is con-
sidered a high threat bioterrorism agent because of the relative ease with which its highly resil-
ient spores can be weaponized and dispersed [1–4]. Renewed interest in developing rapid
diagnostic tools and effective medical countermeasures against anthrax was generated subse-
quent to the anthrax letter attacks in 2001 [5,6]. We sought to determine whether carbohy-
drates located on the B. anthracis (Ba) vegetative cell have structural or immunochemical
properties suitable for the development of new and improved medical counter-measures, such
as improved diagnostics, vaccines and targeted immunotherapies.
B. anthracis is a member of the B. cereus (Bc) group of related species that also includes B.
thuringiensis. These species show high DNA sequence similarities, but display an array of path-
ogen and non-pathogen associated phenotypes [7–9]. The considerable variability in their
infection-associated properties and host specificity has primarily been attributed to differences
in the plasmid content [10].
We have previously reported that the structure and composition of HF-released secondary
cell wall polysaccharides (HF-SCWPs) from Ba vegetative cells are not dependent on plasmid
content [11], are specific for Ba and antigenic [12–14]. For example, antisera raised against
live and killed Ba spores react with the HF-SCWP from Ba, but not with the HF-SCWPs from
Bc ATCC 10987, a dairy isolate, or from the type strain Bc ATCC 14579 [11–14]. In an immu-
nological survey with a polyclonal antiserum raised against Ba HF-SCWPs [14], we demon-
strated qualitative serological cross-reactivity with cells and isolated cell walls from Bc strains
capable of causing severe or fatal illness in humans (e.g. Bc G9241 and 03BB87 causing severe
pneumonia) but not with closely related Bc cells and cell walls from non-infection-associated
strains, such as Bc ATCC 10987 and Bc ATCC 14579. This observation suggested a degree of
antigenic structure conservation between SCWPs from infection-associated Ba and Bc strains.
The repeating unit structures for HF-SCWPs from all currently examined Bc group members
are summarized in Fig 1.
We investigated the SCWP structures of two recently isolated Bc strains, strain Bc CI from
Coˆte d’Ivoire and strain Bc CA from Cameroon designated as B. cereus biovar anthracis, that
caused “anthrax-like” disease in great apes [15–17]. These specific B. cereus strains have
recently been identified as the causative agents of severe outbreaks of anthrax-like disease
among a diversity of great apes in the African tropical rain forest environment (see Hoffmann
C, Zimmermann F, et al., Nature 548, 82–99 (2017). We compared these structures to those
from infection-associated and non-infection-associated Bc group members. Our findings
show that the HF-SCWPs of both great ape strains contained the identical HexNAc trisaccha-
ride backbone core structure and Gal modifications known from Ba HF-SCWP. In addition,
their SCWP contains the additional Gal-substitution at 50% of ManNAc residues originally
identified in human infection-associated Bc strains G9241/03BB87/03BB102. Interestingly,
both great ape-derived strains contained an additional, unique disaccharide substitution at
some of the ManNAc residues that varied in percentage between them. The data from strains
Bc CI and CA support the hypothesis of a conserved structural core motif of SCWPs in viru-
lent, infection-associated Bc group strains. We also describe a comparison of the immunoreac-
tivity of these SCWPs with both Ba SCWP polyclonal antiserum (pAb) and monoclonal
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antibody (mAb) EAII-6G6-2-3 specific for Ba [18,19]. The results corroborate the structural
data and further support the existence of an antigenically distinct and structurally conserved
motif in the SCWPs of disease-causing members of the Bc group of related species.
Methods
Bacterial strains and clinical isolates
The strains and isolates used in this study are listed in Table 1.
Use and care of animals
All animal procedures were carried out in strict accordance with recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Specifi-
cally, procedures for antisera production in rabbits were approved by the Institutional Animal
Care and Use Committee (IACUC) of the Centers for Disease Control and Prevention (proto-
col #1420SAIRABC-A1). The rabbits were housed in stainless steel cages. Room temperature
was maintained in a range from 20 to 23˚C; the light/dark cycle was approximately 12 hours
each per d. Water was available to the animals ad libitum and environmental enrichment was
provided e. g. with treats and toys. Rabbits were ultimately euthanized by exsanguination
under anesthesia. There was no direct use of non-human primates per se in our current study;
Fig 1. Currently known secondary cell wall polysaccharide (HF-SCWP) structures of strains from the B.
cereus group. HF-released SCWPs from infection-associated B. anthracis and B. cereus are shown with red
background. The HF-SCWP from the environmental B. cereus strains have a green background. The conserved
aminogycosyl backbone residues are shown in black; the dissenting GalNAc residues found in the repeating unit of
the environmental B. cereus isolates are shown in blue. The Ba CDC684 strain lacks all Gal substituents. For further
Bacillus strain characterization, see Table 1.
https://doi.org/10.1371/journal.pone.0183115.g001
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all Bacillus strains used in this study (Table 1) originally isolated from the great apes were pre-
viously described by Klee et al., [15,16].
Isolation of cell walls from Bc CA and Bc CI vegetative cells
Cell walls were prepared from cultured cells as previously described [12,14] following the mod-
ified procedure as described [25]. The procedure yielded approximately 15–35 mg of cell walls
per liter of cultured cells.
Isolation and purification of SCWP from Bc CA and Bc CI
The SCWPs examined in this study, and their parent strains, are summarized in Table 1
and Fig 1 (adapted from [12,13,26,27] and unpublished results). The SCWPs, bound to pepti-
doglycan via phosphate, were released from the cell walls by treatment with 48% aqueous
hydrofluoric acid (HF) and purified as previously described [12,14,26,27]. Briefly: the cell wall
preparations from the Bc isolates from great apes (strains Bc CA and Bc CI) were treated with
48% HF at 4˚C for 48 h. The reaction mixtures were rotated slowly in an end-over end mixer
to assist solubilization of the cell wall material. The reaction mixtures were then adjusted to
pH 6.5 by rapidly transferring the mixtures directly into an ammonium hydroxide solution
(20% v/v) pre-cooled to -20˚C. The solutions were then dialyzed at 4˚C vs. deionized water for
3 d using 1,000 MWCO dialysis tubing (Spectrapor). Dialysates were concentrated by centrifu-
gal vacuum-evaporation then subjected to ultracentrifugation (100,000 x g; 4˚C, 4 h) to remove
HF-insoluble material, yielding a supernatant containing the solubilized HF-SCWPs (crude
SCWP preparation). The HF-insoluble residue consisted of peptidoglycan fragments and pro-
tein (amino acids) as determined by GC-MS analysis of the heptafluorobutyrate esters [28]
and the TMS-methyl glycosides.
Crude HF-SCWP was dissolved in deionized water, filtered (0.45 μm cellulose acetate)
(Mettler-Toledo Rainin LLC, Oakland, CA, USA), then purified by size exclusion chromatog-
raphy on Superose-12 FPLC column (using “AKTA System”, Amersham) in 50 mM ammo-
nium acetate pH 7.8 (refer to Supporting Information S12 Fig). The eluent was monitored
by UV absorbance (210 nm/260 nm/280 nm) and refractive index, and fractions containing
the SCWP were identified by glycosyl analysis. The HF-SCWP fractions were dialyzed
(MWCO 2,000 Da, Spectra/Por, Spectrum Labs, Rancho Dominguez, CA USA) against water,
Table 1. Bacillus anthracis and B. cereus strains used in this study.
Strain Source Clinical information Reference
B. anthracis Sterne 34F2 Bovine isolate, South Africa, CDC collection Veterinary vaccine [20]
B. anthracis 7702 Institute Pasteur Sterne strain derivative [21]
B. anthracis CDC684 CDC collection Attenuated strain that was misclassified as B. megaterium [19]
B. cereus ATCC 10987 Dairy isolate (1930, Canada) N/Aa [22]
B. cereus ATCC 14579 Type strain, CDC collection N/A [23]
B. cereus G9241 Human blood isolate (1994, Louisiana) Severe pneumonia [24]
B. cereus 03BB87 Human blood isolate, (2003, Texas) Fatal pneumonia [22]
B. cereus CI
(Bc biovar anthracis CI)
Great ape isolate, Coˆte d’Ivoire Fatal infection in great apes [16,17]
B. cereus CA
(Bc biovar anthracis CA)
Great ape isolate,
Cameroon
Fatal infection in great apes [16,17]
aN/A = not available
https://doi.org/10.1371/journal.pone.0183115.t001
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lyophilized and used for NMR, linkage, and immunological analyses. Typical yields were 5 mg
of purified SCWP per 40 mg of cell wall material.
Glycosyl chemical analyses
Glycosyl linkage analysis was performed according to a modification of the method of Ciucanu
and Kerek [29] as described previously [12]. The resulting partially methylated alditol acetates
(PMAA) were dissolved in dichloromethane and analyzed by GC-MS using a DB-1 or SP-2330
capillary column as described [12, 30]. The carbohydrate compositions of the SCWP and
derived fractions were determined by preparing the TMS-methyl glycosides with GC-MS
(electron impact) analysis [31, 32] using a 30-m DB-5 capillary column (J&W Scientific, (Agi-
lent Technologies Inc.) Folsom, CA USA). The absolute configuration of glycosyl residues was
determined by preparing the diastereomeric TMS-(α)-2-butyl glycoside derivatives [33], with
GC-MS analysis on a DB-1 column with comparisons to authentic D-Gal, D-GlcNAc, and
D-ManNAc derivatives.
Reduction of the reducing-end residue of Bc SCWPs
Portions of the Bc CA and CI HF-SCWPs (3–4 mg) were dissolved in water (200 μl) and mixed
with 0.5 mg sodium borodeuteride (NaBD4) in water (200 μl) and reduced for 1 h at room
temp. The reaction was neutralized by adding methanol containing dilute acetic acid, then
evaporated several times from methanol in a centrifugal vacuum-evaporator (Speed Vac,
Thermo-Fisher Scientific), before dialyzing (1000 MWCO membrane) for 1 d vs. deionized
water. The reduced-HF-SCWP (red-HF-SCWP) was rechromatographed on Superose-12,
isolated as described above, and subjected to NMR and linkage analyses as for the native
materials.
Nuclear magnetic resonance analyses
1H spectra and all two-dimensional homo- and heteronuclear spectra of the great ape derived
HF-SCWPs were recorded at 25˚C on a Varian Inova 600 MHz or Varian 800 MHz spectrom-
eter, each equipped with a 3-mm cryogenic probe, using Varian software (Varian Medical Sys-
tems, Palo Alto, CA, USA). The SCWPs released by HF treatment, and purified by Superose-
12 chromatography were exchanged with D2O (99%, 3 repetitions) and dissolved in 200 μl
D2O (“100%”) yielding clear solutions at approximately 7 mg/ml in 3 mm tubes. The
1H-spec-
tra/axes were referenced to 2,2-dimethyl-2-silapentane-5-sulfonate sodium salt (0.1% DSS in
D20) at δH 0.00 ppm, yielding the HOD resonance at 4.78 ppm. Certain samples, available only
in small amounts (e.g., Ba CDC684 HF-SCWP, 400 μg) were dissolved in 90 μl of D2O and
analyzed in 3 mm Shigemi tubes (Shigemi, Inc) using the cryogenic probe. The 13C axis in 2D
analyses was then referenced to the calibrated proton axis, using the Varian software com-
mand “setref1(‘c13)”, an accepted method which uses the referenced proton dimension to cal-
culate the 2nd dimension (13C) according to a mathematical relationship. This procedure
yields most reproducible and consistent referencing in biomolecular NMR, where the natural
abundance of 13C and the % of DSS is too low to allow reliable detection of the DSS carbon sig-
nal, see e.g., Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E.,
Markley, J. L., and Sykes, B. D., "1H, 13C and 15N Chemical Shift Referencing in Biomolecular
NMR," J. Biomol. NMR 6, 135–140 (1995).
1H-1H COSY [34] data were recorded in the absolute value mode with a 6.10 ppm spectral
width and a matrix size of 1024 x 4096 complex points with 8 scans per increment. 1H-1H
zTOCSY [35] was recorded with a mixing time of 150 ms and a matrix of 400 x 4096 at 32
scans per increment. Nuclear Overhauser effect analysis [36] was performed by phase-sensitive
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
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1H-1H NOESY experiments, collected with a 150 ms mixing time and matrix size identical to
that used for zTOCSY, with 64 scans per increment. Carbon chemical shifts and carbon-pro-
ton one-bond correlations were determined with a gradient-selected 1H-13C HSQC [37] col-
lected in the 1H-detection mode. The acquisition time was 0.2 s, and the matrix size was
typically 256 x 2,000 complex points, at 88 to 144 scans/increment with multiplicity distinction
for primary/secondary protons. The coupling constant (j1ch) was set to 150 Hz and the carbon
spectral width was 110 ppm, transmitter offset 65 ppm. Gradient 1H-13C-H2BC spectra [38]
were acquired with a data matrix of 1600 (1H) x 140 (13C) complex points with acquisition
times of 0.2 s (1H) and 22 ms (13C) respectively. Phase-sensitive 1H-13C HMBC spectra were
acquired with 256 x 2048 complex points at 96 to 144 scans/increment. The carbon and proton
sweep widths were identical to HSQC values, and the acquisition time (t2) was 0.27 s. The
HMBC transfer delay was set to 50 ms (10 Hz), and 1-bond J-filter was 150 Hz. Anomeric con-
figurations of the glycosyl linkages were assigned from carbon-proton coupling constants (JC1,
H1) measured for the native SCWP by
1H-13C HSQC analysis without 13C decoupling. The
acquisition time was 0.6 s, collecting 128 scans per increment; the j1ch was set to 160 Hz and
carbon sweep width was 80–120 ppm.
Molecular modeling
Using the GLYCAM Webtool (39), and the associated Glycam06 force field parameters for
carbohydrates [40] we generated several minimal-energy conformers for oligosaccharide
structural segments for representative HF-SCWPs. Both wire-frame and space filling rendi-
tions of these SCWP segments are shown, as described in Results section.
Conjugation of HF-SCWPs to protein carriers
To facilitate immobilization to polystyrene microtiter immunoassay plates and to make polyclonal
antibody, the HF-SCWP was conjugated to either bovine serum albumin (BSA; Sigma, St. Louis,
Mo) or keyhole limpet hemocyanin (KLH; Sigma) as described by Leoff et al., 2009 [14].
Antibody preparation
Monoclonal antibody (mAb) EAII-6G6-2-3 specific for Ba [10] was obtained from T. Abshire
at the United States Army Medical Research Institute for Infectious Diseases (Fort Detrick,
MD). Polyclonal anti-Ames HF-SCWP-KLH antiserum was generated in rabbits. Briefly, each
of two female (2.0–3.5 kg) New Zealand White rabbits (Myrtle’s Rabbitry, Thompson Station,
TN) was inoculated intramuscularly at two sites in the dorsal hind quarters. Each rabbit was
immunized at 0, 14, 28, and 42 d with a total of 500 μg (primary vaccination) or 250 μg (all
other vaccinations) of the Ba Ames HF-SCWP-KLH conjugate (1.0 mL total volume using
Sigma Adjuvant System (Sigma, St. Louis, MO)). Serum used in this study was collected 14 d
after the final immunization. All animal work was conducted with CDC IACUC approvals.
Immunosorbent assay analyses
Monoclonal (mAb) and polyclonal (pAb) immuno-analyses were done using HF-SCWP con-
jugated to BSA (Sigma, St. Louis, MO) in electrochemiluminescent (ECL) immunosorbent
assays (MSD; Meso Scale Discovery, Gaithersburg, MD). Each SCWP-BSA conjugate was
adjusted to a concentration of 2 μg/mL total carbohydrate content in 0.01 M PBS pH 7.4.
25 μL of the concentration adjusted SCWP-BSA conjugates and 25 μL of 1 μg/mL of BSA pro-
tein (negative control) were incubated at +4˚C for 16–18 h. For use, plates were washed, aspi-
rated, and 150 μL of blocker (0.01 M PBS pH 7.4, 0.5% Tween-20, 5% skim milk [BD, Franklin
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Lakes, NJ]) was added to each well (60 min; 20–25˚C). Plates were washed three times with
wash buffer (0.01 M PBS, pH 7.4, 0.1% Tween-20) on an automated plate washer (BioTek
ELx405, Winooski, VT).
Monoclonal antibody EAII-6G6-2-3 was evaluated over a range of 93.6 μg/mL to 0.0731 μg/
mL in the blocker buffer (60 min; 20–25˚C). After washing, bound EAII-6G6-2-3 was detected
with MSD sulfo-tagged goat anti-mouse IgM detection antibody at 2.5 μg/mL and incubated
at room temperature for 1 h with shaking. The conjugate was detected using MSD Read Buffer
and plates were analyzed using a MSD SECTOR imager for emission at 620 nm.
Rabbit pAb was detected with 2.5 μg/mL of sulfo-tagged goat anti-rabbit IgM (MSD, Gai-
thersburg, MD). To assess the reactivity of each HF-SCWP sample to polyclonal anti-Ames
SCWP-KLH, antiserum was added in two fold serial dilutions starting at 1/100 for each strain
to generate a full dilution curve. Response curves were fitted to a 4 parameter logistic (4-PL)
nonlinear regression model for quantitative analysis [41].
The quantitative endpoints for serological analysis were the effective concentration of mAb
EAII-6G6-2-3 generating a 50% response (EC50) and the effective dilution of rabbit pAb gener-
ating a 50% response (ED50). The EC50 and ED50 values were determined as the reciprocal of
the dilution corresponding to the inflection point (‘c’ parameter) of the 4 parameter logistical
(4-PL) model to fit a dose-response curve to the data as described [41]. Reportable values were
the geometric mean (GM) ED50 and EC50 values from three independent experiments. GM
reactivity for each of the individual strains were compared using Student’s t-test with a
P = 0.05 level of significance. Low EC50 values and high ED50 values indicated a high level of
reactivity against specific HF-SCWP.
Results
Nuclear magnetic resonance (NMR) spectroscopy of the HF-SCWPs
from Bc great ape isolates and comparison to human infection-
associated Bc HF-SCWPs
We have previously reported detailed NMR analysis of Ba derived SCWPs [12, 26], and human
infection-associated Bc derived HF-SCWPs [27]. For comparison, the NMR parameters from
one of the previously examined human infection-associated HF-SCWPs (from strain Bc G9241)
are reported in Table 2, along with those from the great ape isolate B. cereus Cameroon (Bc
CA). Our initial 1H-NMR analysis of the HF-SCWPs isolated from the Bc CA and Bc CI strains
indicated that their structures were probably similar to those of the human infection-associated
Bc G9241 and Bc 03BB87 strains, although with some interesting and significant differences in
their 1H spectra (Fig 2). A number of points were noted in these proton spectra: (i) HF-SCWPs
from both great ape isolates appeared to contain all of the NMR anomeric signals as found in
the Bc G9241 HF-SCWP [27], however the ratios of these resonances were altered in both great
ape isolates, compared to the Bc G9241; (ii) in addition to these “identical” components, both of
the great ape isolates displayed two additional “new” signals in the anomeric region, not previ-
ously observed in the Bc G9241 and Bc 03BB87 human infection-associated strains. These new
components were designated residues J and K, and their NMR parameters are listed in Table 2,
along with the NMR parameters of all other repeating unit components.
Comparison HF-SCWP from Ba strains and infection-associated Bc
strains
All of the Ba strains examined to date, including Ba Ames, Ba Pasteur, Ba Sterne 34F2, Ba
7702, and Ba CDC684 [12, 26], as well as examined strains of human infection-associated Bc
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
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Table 2. 600-MHz 1H and 13C NMR parameters observed for the HF-released secondary cell wall polysaccharide released by HF treatment of great
ape isolate B. cereus strain CA cell wallsa.
Compound Glycose Residue
(JC1,H1 Hz)
δH ppm
δC ppmb
1 2 3 4 5 6
B. cereus (CA) red-HF-SCWP
A0 !3,4,6)-α-D-GlcpNAc-(1!
(179.5) 5.77 4.15 3.98 4.06 3.86 4.11/4.11
96.46 52.77 75.32 76.96 69.88 68.02
Ac!3,4,6)-α-D-GlcpNAc-(1! (177.0)
5.23 4.08 4.01 4.03 3.95 4.12/4.12
99.08 53.43 75.56 76.96 71.47 67.28
Bc!4)-β-D-ManpNAc-(1! (165.0)
4.90 4.50 4.07 3.68–3.73 3.51 3.89/3.81
99.22 54.40 73.21 76.10 75.45 61.1
B0 !3,4)-β-D-ManpNAc-(1! (165.1)
4.91 4.65 4.24 4.09 3.52 3.89/3.75d
99.45 54.29 80.09 77.26 75.45 60.6
B0 0 !3,4)-β-D-ManpNAc-(1! (165.1)
4.91 4.66 4.27 4.10 3.53 3.91/3.76d
99.45 54.29 80.09 77.26 75.55 60.6
C!3,4)-β-D-GlcpNAc-(1! (159.4)
4.65 3.91 3.91 4.10 3.52 3.92/3.71d
101.24 54.94 75.80 77.28 75.90 60.7
D α-D-Galp-(1! (178.5)
5.67 3.79 3.72 3.98 3.82 ~3.71/3.71
97.84 69.34 70.08 69.61 71.57 61.27
D0 α-D-Galp-(1! (177.1)
5.62 3.80 3.73 3.99 3.82 ~3.71/3.71
98.22 69.34 70.08 69.61 71.57 61.27
E α-D-Galp-(1! (177.0)
5.54 3.75 3.71 3.98 3.85 ~3.73/3.73
99.31 69.54 70.08 69.65 71.68 !
E0 α-D-Galp-(1! (177.1)
5.51 3.75 3.72 3.97 3.85 ~3.73/3.73
99.53 69.54 70.08 69.65 71.68 61.44
Fc β-D-Galp-(1! (163.7)
4.43 3.52 3.63 3.93 3.65 3.82/3.82
103.41 71.69 73.19 69.20 76.19 61.60
G α-D-Galp-(1! (173.0)
5.05 3.76 3.66 3.93 4.15 3.73/3.73
101.35 68.63 70.02 69.91 72.06 62.32
J!3)-α-D-Galp-(1! (173.0) 5.11 3.91 4.18 4.18 3.73 3.63/3.54
101.11 67.03 77.20 65.84 72.80 63.18
K α-D-Galp-(1! (172.0) 5.13 3.85 3.92 4.01 4.09 3.73/3.73
95.33 68.90 68.73 71.43 71.52 61.6
B. cereus G9241 HF-SCWPe
A0 !3,4,6)-α-D-GlcpNAc-(1! (178.7)
5.79 4.15 3.99 4.07 3.86 4.14/4.14
96.61 52.79 75.56 77.70 69.98 68.0
Ac!3,4,6)-α-D-GlcpNAc-(1!
(177.0)
5.21 4.08 4.01 4.03 3.96 4.14/4.13
99.19 53.43 75.72 77.06 71.47 67.4
Bc!4)-β-D-ManpNAc-(1! (165.0)
4.90 4.50 4.05–4.10 3.67–3.73 3.51 3.91/3.82
100.04 54.51 73.41 76.20 75.35 61.20
B0 !3,4)-β-D-ManpNAc-(1! (165.1)
4.91 4.65 4.24 4.10 3.52 3.91/3.89
99.40 54.51 80.28 77.27 75.56 60.7
C!3,4)-β-D-GlcpNAc-(1! (159.4)
4.65 3.90–3.91 3.90 4.10 3.52 3.92/3.74
101.54 55.15 75.98 77.31 75.99 60.7
D α-D-Galp-(1! (178.7)
5.68 3.80 3.71 3.98 3.81 ~3.72/3.72
97.91 69.54 70.19 69.76 71.70 61.4
(Continued )
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G9241 and Bc 03BB87 [27] share an identical SCWP glycosyl backbone which consists of a lin-
ear HexNAc trisaccharide repeating unit:!4)-β-D-ManpNAc-(1!4)-β-D-GlcpNAc-(1!6)-
α-D-GlcpNAc-(1!, designated here as:!4)Bβ(1!4)Cβ(1!6)Aα(1! to conform with pre-
vious nomenclature (26). With the exception of Ba strain CDC684, these polysaccharide back-
bones are highly galactosylated with α- and β-Gal residues, and the galactosylation pattern
(location, linkage, anomeric configuration) is species/strain specific. HF-SCWPs from all
examined Ba strains share the same overall galactosylation pattern yielding the hexasaccharide
repeating unit shown in Fig 2A. Thus, the ratio of Gal substitution to HexNAc backbone resi-
dues is 1:1, which represents a high density of side chain attachment for a polysaccharide. In
these Ba derived HF-SCWPs, a small percentage of the repeating units typically lack one or
more of the Gal substituents, contributing to signal heterogeneity in their NMR spectra. This
heterogeneity in Gal side residue attachment is observed in all the examined Ba and Bc derived
HF-SCWPs.
In the human infection-associated Bc derived HF-SCWPs, a single additional Gal substitu-
tion is introduced at 50% of the backbone ManNAc residues, yielding the repeating structure
and spectrum shown in Fig 2B. These Bc derived HF-SCWPs essentially consist of two types of
repeating units, one with, and one without the Gal-substituted ManNAc. The introduction of
this additional Gal residue modifies the magnetic environment of adjacent residues, such that
Table 2. (Continued)
Compound Glycose Residue
(JC1,H1 Hz)
δH ppm
δC ppmb
1 2 3 4 5 6
D0 α-D-Galp-(1! (177.3)
5.63 3.80 3.72 3.99 3.81 ~3.72/3.72
98.33 69.54 70.19 69.76 71.70 61.4
E α-D-Galp-(1! (177.0)
5.55 3.76 3.72 3.99 3.83 ~3.83/3.74
99.40 69.76 70.19 69.76 71.70 61.6
E0 α-D-Galp-(1! (177.1)
5.52 3.76 3.71 3.98 3.86 ~3.83/3.74
99.62 69.76 70.19 69.76 71.70 61.6
Fc β-D-Galp-(1! (163.7)
4.44 3.54 3.64 3.94 3.66 3.82/3.75
103.48 71.70 73.30 69.33 76.21 61.8
G α-D-Galp-(1! (172.6)
5.05 3.77 3.65 3.93 4.15–4.20 3.73/3.73
101.56 68.68 70.19 69.97 72.13 62.46
The Bc strain CA HF-SCWP was purified by Superose chromatography, then reduced with borodeuteride (red-HF-SCWP) prior to NMR analysis. Chemical
shifts for the HF-SCWP derived from B. cereus strain CI are essentially superimposable with those of CA. For comparison, the parameters for the human
infection-associated B. cereus G9241 HF-SCWP are also recorded (previously published [27], from Forsberg et al., 2011).
Additional signals: pyruvate: C1, (C = O) δ 177.04, (C2) δ 100.70, (C3) CH3 δ 25.29, CH3 δ 1.55; N-acetyl: βGlcNAc, C = O δ 174.46, CH3 δ 22.93, CH3 δ
2.08; αGlcNAc, C = O δ 176.20, CH3 δ 20.99, CH3 δ 2.08; βManNAc, C = O δ 175.97, CH3 δ 22.93, CH3 δ 2.03; α-reducing end:!3,6,4)-α-D-GlcpNAc,
H1/C1 δ 5.13/91.67 (JC1,H1 171.1 Hz), H2/C2 δ 4.06/53.5, H3 δ 3.94, H4 δ 3.83, H5 δ 3.75, H6 not assigned; β-reducing end: H1/C1 δ 4.74/95.32, H2/C2 δ
3.79/56.12, H3/H4/H5 = δ 4.07/3.87/3.51; H6 not assigned.
a 600 MHz spectra measured at 25˚C in D2O relative to internal DSS (δH 0.00 ppm). The chemical shifts and other spectral parameters for strains Bc CA
and CI are virtually identical, except for differences in signal area ratios.
b carbon δC obtained from 1H-13C HSQC spectra; carbonyl δC from the HMBC spectra.
c additional heterogeneity exists for residues A and F, for all strains, as described previously for Bc G9241 [27]. The major spin systems A and A0 are listed
above in Table 2; less abundant systems (A0 0, D0, F0, F0 0 etc.) arise from non stoichiometric attachment of Gal residues. Heterogeneity at residue B, arises
from nonstoichiometric substitution of B with residues G, or (J + K), yielding B0 and B0 0 respectively.
d assignments may be interchanged
e for comparison, the parameters for the Bc G9241 strain HF-SCWP are also recorded (previously published [27] from Forsberg et al., 2011).
https://doi.org/10.1371/journal.pone.0183115.t002
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
PLOS ONE | https://doi.org/10.1371/journal.pone.0183115 August 23, 2017 9 / 31
their anomeric signals split, yielding twin signals, where one member of each pair arises from
repeats which lack the Gal-ManNAc, and the other member signal arises from repeats which
carry the Gal-substituted ManNAc [27]. Other ring positions are affected to lesser extents. The
additional Gal attachment on these Bc derived HF-SCWPs results in polysaccharides having a
side residue/backbone ratio of> 1:1. An extensive NMR comparison of the Ba-derived and
human infection-associated Bc-derived HF-SCWPs was previously described [27] and repre-
sentative HSQC spectra are included here for reference (Supporting Information S1 Fig).
In our present study, the NMR anomeric region of the great ape derived Bc strain CA
HF-SCWP is compared with Ba and human infection-associated Bc derived HF-SCWPs in Fig
2C. The “new” signals are indicated, and their associated spin systems and residue identifica-
tion are described in the following sections. Signals originally appearing in the Ba samples are
again split into “twin signals”, but the splitting ratio is not 50/50, reflecting the fact that the
Gal-substitution on ManNAc is not 50% in the great ape-derived SCWPs. This feature, a lower
Fig 2. Comparison of the proton NMR spectra anomeric regions and repeating unit structures of
HF-SCWPs from representative B. anthracis and related B. cereus strains. (A) B. anthracis Sterne 34F2; (B)
the close phylogenetically related human infection-associated B. cereus strain G9241; (C) a great ape isolate, B.
cereus strain CA (Cameroon). All SCWPs share a conserved HexNAc backbone; the Ba strains lack Gal
substituents on the backbone ManNAc residue, while the examined human infection-associated Bc strains (G9241
and 03BB87) exhibit a Gal monosaccharide substitution (residue G) on a percentage of their ManNAc [27]. The
great ape Bc isolates exhibit variable degrees of Gal monosaccharide and Gal disaccharide substitutions (residues
G, J, and K) at ManNAc, which results in additional ManNAc signal heterogeneity (B, B0, and B0 0). The repeating
unit structures of the Ba and human infection–associated Bc HF-SCWPs (panels A and B), including glycosidic
sequence and linkage positions, were deduced from 1H-13C HMBC, 1H-1H-NOESY, and chemical linkage analysis,
previously published [12,26,27].
https://doi.org/10.1371/journal.pone.0183115.g002
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percentage Gal-substitution at the backbone ManNAc residue, is observed to an even greater
degree with the great ape Bc strain CI HF-SCWP. The 1H-anomeric regions of Bc CI, Bc CA,
the human infection-associated strain Bc G9241, and Ba Sterne 34F2 are all compared in S2
Fig, demonstrating their relationship and differences. The 1H-1H TOCSY spectra of the great
ape Bc CA HF-SCWP and the previously analyzed human infection-associated Bc G9241
HF-SCWP are compared in S3 Fig, demonstrating the similarity of the conserved residues,
and the presence of new glycosyl systems in the great ape isolate. The 1H-1H TOCSY spectra of
SCWPs from the two great ape isolates Bc CA and Bc CI are compared in S4 Fig demonstrating
their overall similarity.
Identification of new Gal substituents on SCWPs of great ape strains Bc
CA and Bc CI
In Fig 3, we compare the regions of the 1H-NMR spectra where the new, additional signals (J
and K) are observed in the great ape derived HF-SCWPs compared to Bc G9241. This region
also reveals the percentage of ManNAc residues (B0) that are substituted with an α-Gal residue
(G), originally identified in the human infection-associated Bc G9241 HF-SCWP [27]. In Fig
3A, the HF-SCWP from Bc G9241 demonstrates the near 50% substitution of the ManNAc
residue (B +B0) with this Gal(α1!3) substituent (G). In comparison, the HF-SCWPs from
both Bc strains CA and CI (Fig 3B and 3C) appeared to show a lowered ratio of ManNAc sub-
stitution by residue G, as calculated by integration of the anomeric signals for residues G, J,
and (B+B0+B00). Thus, area integration suggested that substitution of ManNAc by G occurs at
a lower percentage in the great ape derived SCWPs, compared to the Bc G9241.
We also initially found that one of the new anomeric signals (assigned residue K, H1 δH
5.13), actually had the same chemical shift as a low-abundance resonance previously observed
in all Ba and Bc HF-SCWPs, and identified as the free reducing end (GlcNAc, α-anomer) of
the polysaccharides [27]. The presence of this free α-reducing end thus interfered with area
integration and spectral characterization of the new residue K in the great ape isolates. To
remove this interference, the Bc CA and Bc CI HF-SCWPs were reduced at the reducing end
with sodium borodeuteride, yielding the reduced-HF-SCWPs (red-HF-SCWP). In Fig 4, the
effect of reduction on the α-reducing end signal is indicated by a decrease in the relative signal
area at K+α, in the Bc CA red-HF-SCWP. Although reduction was incomplete, the area of K
+α was decreased substantially to the point where it was roughly equivalent to the area of resi-
due J, due to removal of mostthe α-reducing end contribution. To further clarify the effect of
reduction on the SCWPs, the 1H-13C-HSQC spectra of the anomeric regions, before and after
reduction, were examined (S5 Fig). These HSQC spectra demonstrate that the NaBD4 treat-
ment was effective in removing both the α- and β- reducing end anomeric signals and it did
not appear to alter the repeating anomeric signals of the HF-SCWPs in any manner. A com-
parison of the TOCSY spectra of this region before and after reduction is also provided (S6
Fig). Having removed interference by the α-reducing end, the identification and location of
the new residues K and J in the red-HF-SCWP samples were investigated.
The JC1,H1 coupling constants for residues J and K were 173.0 Hz and 172.0 Hz (Table 2),
indicating that both residues were probably of α-anomeric form. 1H-1H-COSY and 1H-13C
HSQC analysis identified H2 for each residue, indicating that neither was a 2-amino sugar.
1H-1H COSY, and TOCSY analysis (Fig 5A) revealed weak magnetic transfer beyond position
4 for both residues, consistent with the galacto-configuration. New, hydroxy-methylene pro-
tons, not observed in the Bc G9241 spectrum, were identified in the HSQC spectra of Bc CA
(and Bc CI) for residue J at δ 3.63/3.54/63.18 (H6/C6, S7 Fig), and TOCSY analysis demon-
strated connectivity to J H5/C5 (δH/δC 3.73/72.80, another new signal not observed in the Bc
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
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Fig 3. Expanded region of proton NMR spectra identifying the locations and area ratios of the Gal
substituents on HF-SCWPs from B. cereus strains. (A) human isolate B. cereus G9241; (B) great ape
isolate B. cereus CA (Cameroon); (C) great ape isolate Bc CI (Coˆte d’Ivoire). The α-anomeric signal originates
from the free reducing end of all these polysaccharides, and co-migrates with a new residue (K) in the Bc CA
and Bc CI SCWPs. This reducing end (α-GlcNAc residue) was removed by borodeuteride reduction for
subsequent experiments, to facilitate integration and characterization of the residue K system. The percentage
of Gal (G) and Gal-Gal disaccharide (J+K) substitution at ManNAc residues (B+B0+B@) is estimated by
examination of the signal areas for these residues. The residue G spin system undergoes a shift at several
positions, and is designated residue J, when it is substituted by residue K (refer to Table 2).
https://doi.org/10.1371/journal.pone.0183115.g003
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G9241 HSQC), and subsequently to H4/C4 (δH/δC 4.18/65.84) of residue J (Table 2 and S7
Fig). Additional HSQC and TOCSY spectra comparing relevant regions from the great ape Bc
CA and human infection-associated Bc G9241 HF-SCWPs are shown in S8 and S3 Figs.
The K system was defined with the assistance of HSQC and H2BC one and two-bond cou-
plings for assignment of positions 6 and 5. H2BC revealed methylene protons (δH 3.73/3.73)
which coupled to C6 (δC 61.6) and C5 (δC 71.52), with assignment of H5 (δH 4.09) from a new
Fig 4. Proton NMR spectra comparing the Bc Cameroon HF-SCWP before and after reduction of the
reducing end with borodeuteride. The effect of borodeuteride reduction on the signal at (K + α) is
demonstrated: (A) native Bc CA HF-SCWP before reduction; (B) the Bc CA HF-SCWP after reduction of the
reducing end (red-HF-SCWP). The contribution from the α-reducing end anomeric signal to residue K signal
area was almost completely eliminated by 1 h treatment, allowing unambiguous assignment of residue K
system and area measurements. Following reduction, the K/J ratio appears to approach 1:1, reflecting the
presence of the Kα(1!3)Jα(1! disaccharide. Considerable overlap of the K and J anomeric signals appears
to result in some inaccuracy in the integration, as the HSQC spectra demonstrate that both α- and β- reducing
end anomeric protons were absent following borodeuteride reduction (see S4 Fig).
https://doi.org/10.1371/journal.pone.0183115.g004
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HSQC signal, not present in the Bc G9241 spectrum. Partial TOCSY spectra defining residues
J and K are shown in Fig 5A. The galacto-configuration was assigned to both J and K on the
Fig 5. Partial 1H-1H TOCSY and 1H-1H NOESY spectra defining the features and glycosidic linkages of
residues K, J, and G in the borodeuteride-reduced HF-SCWP from Bc CA. (A) TOCSY, showing intra-
residue connectivities for residues K, J, and G; (B) NOESY, showing inter-residue NOEs for the K1!J3,
J1!B@3, and G1!B03 glycosidic linkages; (C) NOESY at higher intensity, revealing weaker NOEs resulting
from the close proximity of J1 and G1 to the 2-position proton of residues B@ and B0. The δH/δC of B@3, B03, B02,
and B@2 are unique in the HSQC spectra and key indicators of linkage position for the structural features unique
to the great ape SCWP isolates (Table 2 and S7 Fig). In the TOCSY (panel A) the connectivity “J3,4” designates
correlations between J1/J3, and between J1/J4; the J protons H3 and H4 have identical δH (Table 2).
https://doi.org/10.1371/journal.pone.0183115.g005
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basis of weak scalar coupling at H4, the relative downfield shift at H4, and intra-residue NOEs
between H3-H4 and H5-H4 in addition to H3-H5. As described below, GC-MS analysis of the
TMS-methyl glycosides and partially methylated alditol acetates detected elevated levels of Gal
in the great ape HF-SCWPs, compared to the Bc G9241, and failed to detect any other “new”
hexoses.
Location of additional α-Gal substituents (residues J and K) on the great
ape isolates Bc CA and Bc CI HF-SCWPs
In the SCWPs from human infection-associated strains Bc G9241 and Bc 03BB87, the attach-
ment of the α-Gal (here assigned residue G) to the 3-position of 50% of the ManNAc residues
was clearly demonstrated by inter-residue NOEs and trans-glycosidic HMBC connectivities
[27]. This substitution of ManNAc at the 3-position results in a unique signature at ManNAc
B0 H3/C3 (δH/δC 4.24/80.28) which differs from that of the unsubstituted ManNAc residue B
(Table 2), and is unique in the HSQC spectrum. For both great ape derived HF-SCWPs, a
certain percentage of the backbone ManNAc residues were found to be substituted at O3 by
an α-Gal residue (G) (compare residues B and B0, the latter having H3/C3 δH/δC 4.24/80.09,
Table 2). Inspection of the 1H-1H NOESY spectrum for Bc CA red-HF-SCWP revealed an
inter-residue NOE between G1 (δH 5.05) and B03 (δH 4.24), Fig 5B, indicating that Gal is
linked α1!3 to ManNAc in these great ape isolates as well. Most important, further inspection
of the NOESY spectra indicated that the new residue J anomeric proton (δH 5.13) showed only
two strong NOEs, to a proton at δH 3.91 (identified as H2 from COSY) and an NOE to a new
proton at δH 4.27 (Fig 5B), subsequently identified as H3 of a new variant of the ManNAc resi-
due (assigned B00). These results indicated that the α-Gal residue J is also linked to the 3-posi-
tion of a percentage of ManNAc residues, however, the residue J spin system differed from
that of residue G. Inspection of the J spin system defined above suggested that it may itself be
substituted at H3/C3 (δH/δC 4.18/77.20) by an unknown residue. This substituent was readily
identified as the new α-Gal residue K, having a strong inter-residue NOE between K1 (δH
5.13) and J3 (δH 4.18), Fig 5B and 5C, and NOEs to protons J2 (δH 3.91) and (intra-residue) to
K2 (δH 3.85). The resulting glycosidic sequence, Kα1!3Jα1!3B00, was substantiated by a
trans-glycosidic 1H-13C HMBC connectivity between JH1 (δH 5.11) and B00C3 (δC 80.09)
(shown in S9 Fig). The linkage Gα(1!3)B0 was also confirmed by a trans-glycosidic HMBC
between GH1 (δH 5.05) and B0C3 (δC 80.09), as previously observed for the human infection-
associated Bc strains G9241 and 03BB87. Additional confirmation for intra-residue assign-
ments defining the new residues in the Bc CA red-HF-SCWP were confirmed by 2-bond
1H-13C H2BC connectivities observed for JH1/JC2 (δH 5.11/δC 67.03); KH1/KC2 (δH 5.13/δC
68.90), and KH2/KC1 (δH 3.85/δC 95.33) inter alia. shown in S10 Fig.
To further clarify the nature of the new residues and their linkages, chemical linkage (meth-
ylation) analysis was performed and the resulting PMAA derivatives were compared for great
ape derived HF-SCWPs and the previously analyzed human infection-associated Bc G9241
HF-SCWP. Only the great ape derived HF-SCWP yielded low levels of a 3-linked Gal PMAA
derivative, not previously observed with any of the human pathogen derived strains (S11 Fig).
Together these results indicated that HF-SCWPs from great ape derived CA and CI strains
exhibit a nearly identical structure as that from Bc G9241, with one interesting and rather
unusual difference. All contained a portion of their backbone ManNAc residues substituted
with α-Gal at the 3-position (a feature that is lacking in the Ba derived HF-SCWPs). However,
the great ape isolates exhibited a further modification, in which a percentage of the ManNAc
residues carried a Galα1!3Galα1!3 disaccharide substituent. Table 3 summarizes the
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relative percentage of these substituents, estimated from the NMR signal areas of anomeric res-
onances (Fig 3), for these human infection-associated and great ape-isolated Bc strains.
SCWP reactivity with polyclonal anti-Ames SCWP-KLH antibody
For comparative analysis, strains were grouped based on their structural similarity in the ami-
noglycosyl backbone and its galactosyl modifications (Table 4). The HF-SCWPs from all
examined isolates reacted with the polyclonal (pAb) anti-Ames HF-SCWP antiserum. The
highest reactivity was observed with the HF-SCWPs from strains Ba Sterne 34F2 and Ba 7702
(Fig 6, Table 4). There were no significant differences in the reactivity of the pAb serum with
HF-SCWPs from Ba Sterne 34F2, Ba 7702 and infection-associated Bc 03BB87 and Bc G9241
strains (p = 0.17). There was, however, an approximately 35% reduction in pAb binding to the
HF-SCWPs from the great ape disease causing strains Bc CI and Bc CA compared to the infec-
tion-associated Ba and Bc strains (p<0.05). There was an approximately 70% reduction in
pAb binding to the HF-SCWP from the avirulent Ba CDC684 strain and the non-infection-
associated strain Bc ATCC 10987 as well as an approximately 50% reduction of pAb binding to
the HF-SCWP from strain Bc ATCC 14579 when compared to the infection-associated Ba and
Bc strains (p<0.05). The ED50 values obtained with HF-SCWPs from the two non-infection-
associated strains Bc ATCC 14579 and 10987 were statistically different from each other (p
<0.05). However, while there was a significant difference between the HF-SCWP reactivities
from the non-infection- associated type strain Bc ATCC 14579 and Ba CDC684 (p<0.05),
there was no significant reactivity difference between dairy isolate Bc ATCC 10987 and the
highly attenuated, Gal-substitution negative Ba CDC684 strain (p = 0.24).
The HF-SCWP pAb reactivities separated into distinct groups (Table 4). HF-SCWPs from
the strains Ba Sterne 34F2 and Ba 7702 (Structural Group 1 ED50 values: 1746 and 1786,
Table 3. Percent and type of structural substituent at the 3-position of backbone ManNAc residues in
HF-SCWPs from examined infection-associated B. cereus strains.
Strain Percenta and Type of Substitution at ManNAcb Occurrencec
Bc G9241 50% Galα(1!3) 5/10 RUs
Bc 03BB87 50% Galα(1!3) 5/10 RUs
Bc CA 32% Galα(1!3) 3.2/10 RUs
18% Galα(1!3)Galα(1!3) 1.8/10 RUs
Bc CI 28% Galα(1!3) 2.8/10 RUs
10% Galα(1!3)Galα(1!3) 1.0/10 RUs
The isolated HF-SCWPs from B. cereus G9241, Bc 03BB87, Bc Cameroon (CA) and Bc Coˆte d’Ivoire (CI)
strains all contain on average 11 repeating units, consisting of a HexNAc trisaccharide backbone and its
attached Gal side residues. This conclusion is based on two independent methods: integration of NMR
anomeric signal areas (repeating signals compared to reducing end signals; and on the calculated MW as
estimated by SEC chromatography on Superose, see S12 Fig). The structural feature that distinguishes the
Bc derived SCWPs from each other, and from B. anthracis derived SCWPs, is that these pathogenic Bc
strains contain variable amounts of Gal or Gal!Gal disaccharide substituent at the backbone ManNAc
residue in a percentage of their repeating units; all examined Ba derived SCWP lack this substituent.
a estimated from integration of NMR anomeric signals from the free-reducing end and the repeating unit
residues in each HF-SCWP, and confirmed by Kav values obtained by SEC (S12 Fig).
b all of these substituents at ManNAc are at the 3-position
c expressed on the basis of “per 10 RU” (repeating units)
https://doi.org/10.1371/journal.pone.0183115.t003
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respectively; p = 0.4) had similar immuno-reactivities to the human infection-associated
strains Bc G9241 and Bc 03BB87 (Structural Group 2 ED50 values: 1844 and 1878, respectively;
p = 0.42). The immuno-reactivities of these two groups were not significantly different from
each other (p = 0.17, Table 4). HF-SCWPs from the Bc CI (ED50 value: 1143) and Bc CA (ED50
value = 1212) were not statistically different from each other (p = 0.32). The lowest reactivities
were observed with the HF-SCWP from Ba CDC684 (ED50 value: 517), and from the non-
infection-associated strains Bc ATCC 10987 and Bc ATCC 14579 (ED50 values: 547 and 842,
respectively).
HF-SCWP reactivity with monoclonal antibody EAII-6G6
There was a hierarchy of mAb reactivity (EC50 values) with the examined HF-SCWPs
(Table 4). The HF-SCWPs from Ba Sterne 34F2 and Ba 7702 strains had the highest reactivi-
ties (EC50 values of 0.56 and 0.56 μg/mL, respectively), and were not statistically different from
each other (p = 0.48). This reactivity was significantly lower (p< 0.05) for all Bc strains and
isolates evaluated (e.g. the dairy-isolate strain Bc ATCC 10987 had an EC50 from 141.89 μg/mL
Fig 6. Reactivity of polyclonal antibody anti-Ames HF-SCWP-KLH with HF-SCWPs from Bc group
strains using an ECL immunosorbent assay. Meso Scale Discovery (MSD) multi-array high bind 96 well
plates were coated with a fixed concentration of SCWP antigen (2 μg/ml) from different Bacillus species and
probed with the polyclonal antibody in serial two fold dilutions. Bound anti-Ames HF-SCWP-KLH antibody was
detected by 2.5 μg/ml of sulfo-tagged goat anti-rabbit IgM detection antibody. Plates were measured in the
SECTOR imager where a voltage is applied to the plate electrodes and light at 620 nm measured. Data points
are the average of three independent experiments. Error bars represent one standard error. Reactivity reported
as the effective dilution (ED50) titer, midpoint of the curve, in Table 4.
https://doi.org/10.1371/journal.pone.0183115.g006
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and the Bc ATCC 14579 type strain of 223.45 μg/mL). However, all infection-associated Bc
strains displayed distinctly higher reactivity. For example, the human infection-associated
strains Bc G9241 and Bc 03BB87, Structural Group 2, had approximately 10- to 30-fold lower
EC50 values and the great ape isolates, Structural Group 3, approximately 2- to 3-fold lower
EC50 values compared to the non-infection-associated Bc strains (p< 0.05). The variance in
the EC50 values between Structural Group 2 (Bc G9241 and Bc 03BB87, p = 0.13) and between
Structural Group 3 (Bc CA and Bc CI strains, p = 0.32) were not statistically significant. The
HF-SCWP from the highly attenuated Ba CDC684 was of particular interest. This SCWP
comprised the core HexNAc trisaccharide backbone but was devoid of α- and β-Gal substitu-
tions. This HF-SCWP displayed a significantly higher EC50 (lower reactivity) compared to
HF-SCWP from Ba Sterne 34F2 and Ba 7707 (p< 0.05), and from the infection-associated Bc
G9241, Bc 03BB87 and Bc CA and CI (p< 0.05). The reactivity of the Ba CDC684 isolate was
not significantly different to that of the non-infection-associated and structurally unrelated
HF-SCWP from Bc ATCC 14579 and ATCC 10987 (p = 0.18 and 0.21, respectively; Table 4).
Essentially, the HF-SCWP from Ba CDC684, the great ape Bc CA and Bc CI isolates, and the Bc
ATCC 14579 and ATCC 10987 environmental isolates may be considered non-reactive with the
mAb (Fig 7) although the two great ape isolates did show a slightly elevated reactivity compared
to the environmental isolates. Molecular models, generated using the Glycam Webtool [39]
with the corresponding force field parameters for carbohydrates [40] yielded several minimal-
energy conformers allowing us to compare the epitope presentation for representative SCWP
segments from a strong-mAb binder (Ba Ames/Sterne), an intermediate mAb binder (human-
isolate Bc G9241), and a non-binder (Bc ATCC 10987) (Fig 8). Several minimal energy
Fig 7. Reactivity of monoclonal antiserum EAII-6G6-2-3, specific for Ba neutral cell wall
polysaccharide [19], with HF-SCWPs from Bc group strains. Meso Scale Discovery (MSD) multi-array
high bind 96 well plates were coated with a fixed concentration of HF-SCWP antigen (2 μg/ml) from different
Bacillus species and probed with the monoclonal antibody in serial two fold dilutions. Bound antibody was
detected by using 2.5 μg/ml of sulfo-tagged goat anti-mouse IgM detection antibody. Data points are the
average of three independent experiments. Error bars represent one standard error. Reactivity reported as
effective concentration (EC50) titer in Table 4.
https://doi.org/10.1371/journal.pone.0183115.g007
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conformers were generated including gt-gt and gg-gg forms; only the gt-gt conformers are
shown. The possible role of these conformers, including the relative importance of individual
Gal residues in EAII-6G6 recognition is discussed in Fig 8 and in the Discussion.
Comparisons of HF-SCWP structures (Fig 1) indicate that mAb reactivity can distinguish
between the polysaccharide backbones of Ba and Bc based on the galactosylation pattern of
the!4-β-ManNAc-(1!4)-β-GlcNAc-(1!6)-α-GlcNAc-1! backbone. The absence of Gal
Fig 8. Comparison of minimal energy gt-gt conformers for repeating segments from the Ba Ames, Bc G9241,
and Bc ATCC 10987 HF-SCWPs. Top panels (A, C, and E) are wire frame models, absent all hydrogens for clarity;
(bottom panels B, D, F) show their corresponding space filling renditions, with all hydrogens. The space filling models
depict Gals using standard CPK colors (gray = carbon; red = oxygen; white = hydrogen). To distinguish the HexNAc
backbones, all backbone atoms are shown in orange. The Ba Ames segment (panels A, B) is an eleven residue
segment depicting the backbone residue sequence C-A-B-C-A with its six Gal substituents (residues are labeled
according to the scheme presented in Figs 1 and 2 and Table 2). In the equivalent segment from the human infection-
associated Bc G9241 model (panels C, D), the αGal substituent introduced at O3 of ManNAc (shown in yellow) is
clearly noticeable. We propose this substituent could interfere with mAb recognition of the conserved Gal residues
(particularly residues E and F), accounting for reduced mAb affinity for Bc G9241 (Fig 7). In the frame shift shown here
(C-A-B-C-A) ManNAc is shown in the center, since structural alterations at ManNAc are the focal point responsible for
the differences in EAII-6G6 mAb binding. Although not shown here, further attachment of additional Gal in the form of
an (αGal1!3αGal) disaccharide at this location (residues J and K) is proposed to cause additional reduction of mAb
binding (as observed with the great ape derived HF-SCWPs, Table 4). In panels E and F, an “equivalent” segment of
the Bc ATCC 10987 SCWP is depicted; this SCWP consists of a different HexNAc backbone sequence than that
shared by all the pathogenic strains, and with only a single βGal attachment. A labeling nomenclature for the individual
glycosyl residues of this non-binding structure was not assigned, since the overall structure is not shared with any of
the infection-associated SCWPs. The models demonstrate the striking difference in α/β-Gal spatial arrangement
presented by the high-binding, intermediate binding, and non-mAb-binding SCWP. Models were generated using the
Carbohydrate Builder Webtool [39] and the GLYCAM06 force field parameters [40].
https://doi.org/10.1371/journal.pone.0183115.g008
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residues such as in the Ba CDC684 SCWP results in a dramatic loss of binding activity with an
EC50 value of 356 μg/mL compared to a strain with full galactosylation such as Ba Sterne 34F2
with EC50 0.56 μg/mL. The addition of one α-Gal to O3 of the ManNAc residue in Bc G9241
SCWP resulted in a statistically significant reduction in binding (EC50 13.6 μg/mL). The addi-
tion of a second α-Gal, i.e., as the disaccharide substituent [Gal(α1!3)Gal(α1!], to O3 of the
ManNAc residue (refer to Figs 1 and 2, or S2 Fig) in the SCWP of the Bc CI and Bc CA isolates
resulted in further reductions in binding (EC50 49.94 and 64.34 μg/mL, respectively) of the
monoclonal antibody when compared to a monosaccharide α-Gal substitution (Fig 7,
Table 4).
Discussion
Structural investigations of SCWPs from Ba Ames, Ba Sterne 34F2, Ba 7702, Ba Pasteur and
Ba CDC684, and from infection-associated Bc G9241 and Bc 03BB87 showed that their
SCWPs were comprised of a linear aminoglycosyl (HexpNAc) trisaccharide backbone repeat-
ing unit that contains the common structural core motif:!4)-β-D-ManpNAc-(1!4)-β-
D-GlcpNAc-(1!6)-α-D-GlcpNAc-(1! [12,27]. With the exception of the highly attenuated
Ba CDC684, the GlcNAc residues are highly galactosylated with α- and β-Gal [26,27]. The
SCWPs from infection-associated Bc strains had an additional α-Gal substitution on the Man-
NAc backbone residue [27]. Since this aminoglycosyl backbone motif is not present in the
non-infection-associated strains Bc ATCC 14579 and ATCC 10987, we hypothesized [26] that
SCWP molecular structural features (e.g., secondary conformational arrangement and optimal
presentation of the Gal substituents) could have an important functional role in pathogen
development, including such aspects as wall assembly and cell division/cell chain length. Note
that although the HF-SCWP are antigenic, they are not toxic factors and are not considered to
directly contribute to Ba/Bc virulence, however, SCWP may have an indirect role as a result of
their known ability to anchor S-layer proteins and direct localization of S-layer associated pro-
teins (e.g. BSL O) to cell septa.
Previous studies by Ezzell et al. [19] with mAb EAII-6G6-2-3 and Ba derived cell wall frac-
tions showed that its reactivity was inhibited by free monosaccharide galactose and lactose (i.e.
Galβ1!4Glc), but not by GlcNAc. This observation suggested to us that the epitope for this
antibody may be localized in the SCWP, with particular emphasis on the presentation and
arrangement of Gal residues carried on the HexNAc backbone. Modifications in SCWP struc-
tures of the Bc group strains may therefore be correlated to EAII-6G6-2-3 binding. The
recently isolated and phylogenetically well-defined Bc CA and Bc CI causing anthrax-like
symptoms in great apes [15,16] were evaluated to further increase the scope of SCWP struc-
tural analysis in infection-associated Bc.
The results presented here reveal that the SCWPs isolated from great ape infection- associ-
ated Bc CA and Bc CI isolates had SCWP primary structures almost identical to the SCWP
from human infection-associated strain Bc G9241 [27] except that a percentage of the back-
bone ManNAc residues also carry a Galα1!3Galα1!3 disaccharide substituent (Table 3).
Apart from this disaccharide, the SCWP structures from the Bc CA and CI strains contain the
structural features previously identified in infection-associated Ba and Bc strains, i.e. the con-
served aminoglycosyl trisaccharide backbone that is substituted with strain-specific galactosy-
lation modifications at conserved locations.
The structural modifications discovered in the SCWPs from the great ape infection- associ-
ated Bc CA and CI strains compared to the SCWP from Ba raised the question whether these
modifications affect SCWP immuno-reactivity compared to the those of SCWPs from other
infection-associated and non-infection-associated Bc group strains [14]. The data from this
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study indicate that the pAb antiserum did not have sufficient specificity to distinguish between
the HF-SCWPs from the Ba Ames and human infection-associated isolates Bc G9241 and Bc
03BB87. The HF-SCWPs from both Bc CA and Bc CI had similar reactivity, with approxi-
mately a 35% reduction in binding of the pAb relative to HF-SCWPs from the Ba Ames and
human infection- associated isolates Bc G9241 and Bc 03BB87 (Fig 6 and Table 4). There was
a 50% reduction in pAb reactivity to the non-infection-associated strain Bc ATCC 10987, and
an approximately 80% reduction in reactivity to HF-SCWP from the non-infection-associated
strain Bc ATCC 14579 and the nongalactosylated aminoglycosyl repeating motif from Ba
CDC684.
These data suggest that the conserved aminoglycosyl repeating unit backbone, common
only to the Ba strains and the pathogenic Bc isolates, is a predominant antigenic determinant
for the pAb, and that their strain specific, α- and β-Gal substitutions at GlcNAc and at Man-
NAc, confer additional, sometimes unpredictable, polyclonal response. This is emphasized by
the fact that a significant response, well above base line, was observed between the polycolonal
sera and the HF-SCWP from Ba CDC684 (which lacks all Gal substitutions and consists only
of the conserved Ba aminoglycosyl backbone (Fig 1). The polyclonal serum was also somewhat
reactive with HF-SCWPs having a structurally different HexNAc backbone, such as those
from the nonpathogenic strains Bc ATCC 10987 and the type strain Bc 14579. These non-
infection- associated environmental isolates have HexNAc backbone structures that differ
from those shared by the pathogenic Ba and Bc isolates (Fig 1), specifically, [!4)-β-D-Man-
pNAc-(1!4)-β-D-GlcpNAc-(1!6)-α-D-GalpNAc-(1!], and both nonpathogenic isolates
displayed reduced pAb immunoreactivity. Thus the pAb was able to distinguish between the
HF-SCWPs from non-infective isolates and the clinical isolates, although the distinction was
not impressive and the pAb response appears to be rather unpredictable, using any straightfor-
ward molecular model. It is not clear, for example, why the HF-SCWP from the Bc ATCC
10987 and the HF-SCWP from Ba CDC684, having different backbone structures, showed
very similar immunoreactivity with this polyclonal antiserum. The similar immunoreactivity
may be a consequence of both SCWPs containing a conserved!4)-β-D-ManpNAc-(1!4)-α-
D-GlcpNAc-(1! structural element. Likely, it typifies the broad, non-specific nature of poly-
clonal sera compared to a mAb, and further investigation is required to define the exact epi-
tope(s) involved in pAb binding.
In contrast to the polyclonal reactivity, the mAb EAII-6G6 had significantly greater ability
to discriminate between subtleties in SCWP structure (Fig 7). There was approximately a
100-fold reduction in binding of the mAb to HF-SCWPs from both Bc CA and Bc CI, relative
to HF-SCWPs from the Ba Sterne 34F2 or Ba 7702, and a 20-fold reduction in reactivity com-
pared to human infection-associated isolates Bc G9241 and Bc 03BB87. Small differences in
mAb reactivity between isolates Bc G9241 and Bc 03BB87 were also detected, however, these
differences could simply result from experimental variability, for instance, differences in purity
of the two preparations. All of the 2-D NMR signals arising from each of these two Bc human
infection-associated SCWPs were essentially indistinguishable [27], suggesting they are of
identical structure. However low levels of insoluble contaminants (e.g. peptidoglycan frag-
ments), and low levels of a contaminating glycogen polymer vary slightly among different
preparations, and their presence could likely account for the slight displacement of these two
binding curves (Fig 7). Reactivity of the mAb to the non-galactosylated aminoglycosyl repeat-
ing motif from Ba CDC684 was reduced more than 600-fold compared to Ba Sterne 34F2 or
Ba 7702. Reactivity to the differing HF-SCWP structures from Bc ATCC 10987 and Bc ATCC
14579 was reduced by 250- and 400-fold, respectively. Thus, the observed reactivity of EAII-
6G6 with the examined HF-SCWPs (Fig 7) suggests that four main structural groups can be
distinguished with this mAb: 1) non-reactive (Ba CDC684 and the non-pathogenic Bc ATCC
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10987 and Bc ATCC 14579, 2) low reactive (both great ape isolates (Bc CA and Bc CI), 3) inter-
mediate reactivity (human infection-associated Bc G9241 and Bc 03BB87), and 4) highly reac-
tive (Ba Ames, Pasteur, Sterne, and related examined Ba strains). The structural basis of this
reactivity is suggested to reside in the presentation of multiple Gal residues in the proper
3-dimensional conformation. This 3-dimensional arrangement (secondary structure) is opti-
mal only in the Ba derived strains, (with the exception of Ba CDC684 which lacks galactose,
Fig 1). The introduction of an additional Gal residue, at O-3 of the backbone ManNAc residue
(i.e., for Bc G9241 and Bc 03BB87), disrupts this secondary structure of the polysaccharide suf-
ficiently, such that EAII-6G6 binding is reduced. The attachment of further additional Gal,
(i.e., in the form of Galα1!3Galα1! disaccharide to ManNAc in both great ape isolates)
causes further deviation from the optimal secondary structure necessary for mAb recognition,
yielding the weak binding observed with this structural group. One possibility is that approach
of the mAb to the multiple Gal epitope presented by the SCWP is simply hindered by the pres-
ence of the new disaccharide (and monosaccharide) Gal substituents, at ManNAc in these
strains, as visualized by molecular models (Fig 8). Alternatively, the presence of these new sub-
stituents could also result in a change in the overall secondary conformation presented by the
SCWP, compared to that of Ba Ames, Pasteur, Sterne, and related Ba strains. A combination
of these factors may also account for the observed binding differences. It is interesting to note
that HF-SCWPs derived from the nonpathogenic strains (e.g., Bc ATCC 10987 and Bc ATCC
14579), which do not contain the conserved HexNAc trisaccharide backbone of the infection-
associated strains, elicit binding essentially at baseline levels, similar to BSA. The Ba CDC684
HF-SCWP, which does contain the pathogenicity-associated HexNAc backbone but lacks all
Gal substituents, also shows this same lack of reactivity with the EAII-6G6 mAb. Thus, both
the pathogenicity-associated HexNAc trisaccharide backbone, together with the optimal pat-
tern of α/β- attached Gal residues (found only in Ba strains), is required to yield the maximum
binding of EAII-6G6. Molecular models generated using the Glycam web tool [39] with stan-
dard Glycam06 force field parameters [40] yielded several low energy conformers for SCWPs
from three representative strains, Ba (Ames), Bc G9241, and Bc ATCC 10987 (strong, interme-
diate, and non-binding) as compared in Fig 8. These models reveal how additional Gal substit-
uents located at ManNAc could perturb mAb binding and accessibility to the correct Gal
epitope. For instance, Fig 8 shows identical views of a minimal energy gt-gt conformer for an
eleven (or twelve) residue segment for both the Ba Sterne 34F2 and the Bc G9241 HF-SCWPs.
The backbone segments depicted are of the sequence: C-A-B-C-A, with ManNAc (residue B),
depicted in the middle of the segment since this ManNAc residue is the focal point of the
structural difference. Of interest is the close proximity of the α-Gal (E) and β-Gal (F) substitu-
ents at the 6-linked GlcNAc (residue A) to each other, as well as their close proximity to the α-
Gal monosaccharide substituent (residue G) at ManNAc in the Bc G9241 segment. We pro-
pose that accessibility of these two Gal residues (E and F) to the mAb could be reduced by the
presence of a monosaccharide Gal substituent at ManNAc (as in the human isolate Bc G9241),
and further reduced by the presence of a Galα1!3Gal disaccharide at ManNAc, resulting in
the weaker binding for the great ape isolates (Fig 7). The particular low energy conformer
depicted in Fig 8 also suggests the possibility that exposed portions of the two closely located
Gal residues (E and F) might contribute, perhaps equally, to the EAII-6G6 epitope. Note also
that the SCWP from Bc ATCC 10987 does indeed carry a β-Gal substituent, yet is essentially
non-reactive with the mAb EAII-6G6 (Fig 7, Table 4). This observation is consistent with the
hypothesis that the Ba-conserved “pathogenicity motif” backbone is essential in presenting the
Gal substituents to the mAb, by providing the proper conformational scaffolding. Although
not proven here, we suggest the possibility that the combined arrangement of both Gal resi-
dues E and F may contribute to the EAII-6G6 epitope. The HexNAc backbone itself probably
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does not interact directly with the mAb, (note the non-binding observed with the Ba CDC684
SCWP, Fig 7), however, this pathogenicity-specific backbone is necessary to provide the
proper scaffolding for presentation of the multiple Gal epitopes which do interact with the
mAb. The models provide a visual assist to our central hypothesis, that the correct number of
Gal residues, carried on the proper HexNAc backbone at specific locations, are required for
optimal mAb EAII-6G6 recognition. Removal or addition of Gals or any change in the Gal
attachment pattern, from that displayed in Ba strains, results in variable degrees of attenuation
of mAb binding.
The aminogycosyl backbone is also likely to be of importance for the SCWP immunoreac-
tivity with the mAb, as shown with the nearly abrogated reactivity of SCWP samples from the
non-infection-associated Bc isolates. In contrast to the conserved core repeating trisaccharide
backbone of the infection-associated Ba and Bc strains, the HF-SCWPs of Bc ATCC 10987 and
the Bc type strain ATCC 14579 possessed entirely different backbone repeating structures [13,
42]. Presumably due to the differences of the aminoglycosyl backbones of these strains, they
presented significantly higher EC50 values when compared to the Ba Sterne 34F2 and Ba 7702
strains.
The EAII-6G6-2-3 antibody has been used in diagnostic tests and to probe for the distribu-
tion of the EAII-6G6-2-3 epitope in SCWPs of Bc group strains. De et al. analyzed 230 Ba iso-
lates with a two component direct fluorescent antibody (DFA) assay using fluorescein labeled
EAII-6G6-2-3 against the cell wall polysaccharide antigen and a monoclonal antibody against
the capsule antigen [18]. Of the 230 Ba isolates tested, 228 were positive for reactivity with
EAII-6G6. The assay specificity for EAII-6G6-2-3 was only 78.6%, and almost 100% of the
false-positive isolates were Bc or Bacillus thuringiensis strains. Ten of 23 (43%) B. cereus strains
were reported positive for the cell wall antigen. Further DFA analysis of B. cereus strains
G9241 and 03BB87 were also positive for cell wall polysaccharide antigen [22, 24], whereas
that of Bc ATCC 14579 was negative [18].
We suggest that the mAb antibody is recognizing a specific epitope in the cell wall polysac-
charide antigen, which is impacted by number and position of galactose modifications. While
we have shown that removal of all Gal residues (Ba CDC684) causes loss of binding and the
addition of Gal to ManNAc reduces binding (Bc G9241/03BB87, and Bc CA and CI), we do
not yet know the specific contributions of each of the three Gal residues in the Ba structure
that provides optimal binding. Our minimal energy models (Fig 8) suggest a preliminary pos-
sibility that Gal residues E and F may together contribute to the EAII-6G6 epitope. A detailed
analysis of the minimal Ba SCWP epitope and Gal positions required for EAII-6G6-2-3 bind-
ing is being investigated by preparing synthetic structural analogs. Further, while we know
that the terminal repeat unit is pyruvylated, O-acetylated, and de-N-acetylated [26], we do not
know the extent of their contribution, if any, to the mAb-epitope. However, all of our data sug-
gest that these non-carbohydrate substituents are not key elements of the EAII-6G6 epitope.
For instance, HF-SCWPs from all of the examined strains, (all pathogenic Ba strains, the Ba
CDC684 non galactosylated strain, the human isolates Bc G9241 and Bc 03BB87, the great ape
isolates Bc CA and CI, and both ATCC environmental strains), carry a pyruvate residue at
identical location on the terminal repeating unit as reported here (S3, S5 and S7 Figs) and dis-
cussed in (26), however, only the galactosylated strains containing the pathogenicity-associated
HexNAc backbone demonstrate significant EAII-6G6 binding.
It has been established that cell wall polysaccharides can be virulence factors in both Gram-
positive and Gram-negative pathogens [43–45] and are used as diagnostic targets [46,47] or as
carbohydrate-based vaccine antigens [48,49]. For instance, the galactomannan cell wall poly-
saccharide of Aspergillus fumigatus, an opportunistic fungal pathogen, is an antigen that is the
basis for a diagnostic test against the tetra-β-(1!5) galactofuran chain [50]. As such, cell wall
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polysaccharides amongst the closely related B. cereus group may be useful in development of
rapid diagnostic tests for inhalation anthrax.
Monoclonal antibody EAII-6G6-2-3 has been used and previously published as a differen-
tial diagnostic reagent for B. anthracis [18], and it is still used at CDC for immunohistochemis-
try tests in tissue. We demonstrated that the ability of mAb EAII-6G6-2-3 to distinguish
between disease causing strains of the Bc group is based on the number and position of galac-
tosyl modifications around a secondary cell wall polysaccharide backbone. So far, in Bacillus
species capable of causing infection this polysaccharide was comprised of!4)-β-D-Man-
pNAc-(1!4)-β-D-GlcpNAc-(1!6)-α-D-GlcpNAc-(1! and we propose that this aminogly-
cosyl core constitutes a pathogenicity-related motif associated with Bacillus infectivity. In
addition, a putative association between pathogenicity and the galactosyl modifications is
emerging. Based on the reported in vivo activities of the various strains evaluated here, the
presence and relative positions of the modifications may be associated with relative infectious
potency. For example, all the strains containing the!4)-β-D-ManpNAc-(1!4)-β-D-Glcp
NAc-(1!6)-α-D-GlcpNAc-(1! core motif are associated with human disease or capable of
causing fatal infection in animal models. However, the Ba CDC684 strain lacking galactosyl
residues is highly attenuated in a guinea pig model of infection whereas the galactosylated Ba
Sterne 34F2 and Ba 7702, although lacking the poly-D-glutamic acid capsule virulence factor,
retain a significant level of virulence in mouse and rabbit models of anthrax [51]. The accumu-
lating data are increasingly indicative of the aminoglycosyl core motif as a marker of pathoge-
nicity and it is tempting to speculate that the core motif in its glycosylated form may be a
putative pathogen associated molecular pattern that enhances the capability of the organism to
cause infection.
Supporting information
S1 Fig. Partial 1H-13C HSQC spectra comparing the anomeric regions of representative
HF-SCWP from human infection-associated Bacillus strains. (A) Bc G9241; (B) B. anthracis
Sterne 34F2. For complete details of this structural comparison see [27] Forsberg, et al., Glyco-
biology (2011) 21:934–948. The anomeric signals circled in red are unique to the human infec-
tion-associated Bc strains, and absent from Ba Sterne, Ames, and Pasteur strains. Their
presence reflects an alteration in magnetic environment due to 3-O-substitution of 50% of the
ManNAc residues (B0) with αGalρ residue (G) in the Bc G9241 SCWP; the α/β-GlcNAc signals
arise from the reducing-end residue of the HF-released SCWPs [27].
(TIF)
S2 Fig. Structural relationship and comparison of the 1H-NMR anomeric regions for
HF-SCWPs from B. anthracis Sterne, the representative human infection-associated B.
cereus strain G9241, and the great ape isolates B. cereus CA and Bc CI. New anomeric sig-
nals (from residues J and K) are indicated. Signals having a unique downfield shift, diagnostic
for 3-substituted ManNAc (B03, B003) are also labeled and are present only in the Bc infection-
associated strains (refer to Table 2).
(TIF)
S3 Fig. Comparison of 1H-1H-TOCSY spectra for HF-SCWPs from (A) B. cereus CA
(Cameroon), and (B) human infection-associated B. cereus G9241. Consistent with S2, S4,
S7 and S8 Figs the TOCSY spectra from these two strains are virtually identical and superim-
posable, except for the presence of the additional residues J and K in Bc CA SCWP. In panel A,
the (red box) shows the TOCSY region expanded in S6A Fig. In panel B, the human isolate Bc
G9241 lacks the J and K spin systems. All other TOCSY connectivities detected in the great
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ape Bc CA and Bc CI isolates are virtually identical to those from the human infection-associ-
ated HF-SCWPs; these signals arise from the conserved residues that are shared with, and pre-
viously identified [27] for the human infection-associated strains (Bc G9241/Bc 03BB87/Bc
03BB102), as represented in panel B. The chemical shifts of these conserved residues are
remarkably similar in these HF-SCWPs. For example, all examined HF-SCWPs show connec-
tivities arising from the α- and β- reducing end GlcNAc residue on each polysaccharide
(labeled α/β). These weak spin systems are listed in the Table 2 footnote: “Additional Signals”.
Positional assignments from COSY analysis (not shown) have been previously published for
this reducing end residue from Ba and Bc strains [26,27]. Their resonances are virtually super-
imposable and show very little variation in each polysaccharide examined, including the great
ape isolates described here. Also refer to the 1H-13C-HSQC in S7 Fig, which shows the H2/C2
correlation for the reducing end residue. Other substoichiometric signals—Residue C0 is a 3-O-
acetylated variant of C, which also occurs at a specific location in each HF-SCWP molecule
from all examined strains [26]. Shown is the H3 proton of this residue, a doublet of doublets;
also note its presence as a “reporter signal” in S5 Fig, showing the 1H-13C HSQC (H3/C3 δH/
δC 5.09/74.2). Residue C0 was first identified in the B. anthracis strain CDC684 HF-SCWP [26]
and was subsequently detected in Ba Sterne 34F2, Bc G9241 [26], and in the present work in
both great ape-derived Bc strains. Of further interest, in all examined HF-SCWPs the attached
Gal substituents D, E, and F all display signal heterogeneity, which appears to arise from non-
stoichiometric Gal attachment in some of the repeating units. The weak system at δH 5.39 ()
arises from the anomeric proton of 4-linked α-glucose residues, due to variable amounts of a
contaminating glucan produced by the bacteria. The majority of this glucan was removed
prior to NMR analysis by Superose-12 chromatography (S12 Fig) as previously described for
Ba and Bc SCWPs [26, 27].
(TIF)
S4 Fig. Comparison of 1H-1H-TOCSY partial spectra for HF-SCWPs from the great ape
isolates. (A) B. cereus CA (Cameroon), and (B) B. cereus CI (Coˆte d’Ivoire). These TOCSY
spectra are virtually superimposable, reflecting the structural similarity of the SCWPs from
these two great ape isolates. This is consistent with the 1H anomeric NMR spectra (S2 Fig.)
which indicated differences only in signal area for these two strains, with identical chemical
shifts.
(TIF)
S5 Fig. Comparison of the 1H-13C-HSQC anomeric regions for native and borodeuteride-
reduced B. cereus Cameroon HF-SCWPs. A, native Bc CA strain HF-SCWP, and B, the same
sample reduced with borodeuteride to remove the anomeric signal from the reducing end
(converting this residue to alditol) allowing elucidation of the K residue system. Arrows show
the location of both α- and β- reducing end (GlcNAc) anomeric signals prior to reduction;
note their absence in the red-HF-SCWP (panel B). These spectra demonstrate that reduction
did not appear to affect any other residues, only the free reducing end. The locations of new
residues J and K (anomeric signals) and all other anomeric signals from the repeating units
were unchanged. Note also the presence the of δH downfield-shifted O-acetyl “reporter” signal,
which arises from the H3 proton on a 3-O-acetylated β-GlcNAc residue (C0); this O-acetylated
GlcNAc residue occurs at a specific, non-repeated location in all Ba and pathogenic Bc derived
HF-SCWPs examined to date [26]. The scalar connectivities for this residue are visible in S3
Fig. A detailed description of the location and identity of this and other substoichiometric
modifications is presented in Forsberg et al., [26].
(TIF)
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S6 Fig. Comparison of 1H-1H TOCSY spectra for the Bc CA HF-SCWP showing the region
containing residues J, K, and G, before (A), and after (B) reduction of the reducing end of
the SCWP with borodeuteride. In panel A, α = α-reducing end GlcNAc anomeric proton.
Certain scalar correlations arising from this α-reducing end anomeric proton overlapped with
some of the K residue protons; removal of these α-reducing end signals by borodeuteride
reduction allowed definitive assignment of the K ring system (panel B). The β-GlcNAc reduc-
ing end anomeric is found at δH 4.74 (refer to S3, S5A, and S8 Figs and the Table 2 footnote:
“Additional Signals”).
(TIF)
S7 Fig. Partial 1H-13C HSQC spectra comparing HF-SCWPs from Bc strains: (A) human
isolate Bc G9241; (B) great ape isolate Bc CA (Cameroon). Proton multiplicity is indicated
by peak polarity, i.e., orange/red gradient signals (positive polarity) arise from methyl or
methine ring protons, and blue/pink gradient signals (negative polarity) arise from methylene
(-CH2-) protons. Distinct signals arising from position H6/C6 of residue J (“J6”) were ob-
served in Bc CA (also Bc CI, not shown), which were absent in the human Infection-associated
Bc G9241 and Ba strains (previously published [26,27]). In addition, a 1H-13C H2BC analysis
provided 2-bond couplings which assisted in residue J assignments (S10 Fig). Pyruvate
"reporter signals" and the location of pyruvate in HF-SCWPs from representative Ba and Bc
strains is discussed in detail in Forsberg et al., 2012 [26]. Briefly, pyruvate ketal is linked to
positions 4 and 6 of the terminal, non-reducing end ManNAc residue, designated B0. This sub-
stitution precludes further chain polymerization. At B0 positions 4, 5, and 6, unique δH/δC
result from this pyruvate substitution (yielding unique “reporter signals”). A 3-bond 1H-13C
HMBC coupling was also observed between the pyruvate C2 carbon, and a favorably oriented
H6 proton of B0 for all examined HF-SCWP [26]. These and other reporter signals, arising
from substoichiometric modifications (e.g., O-acetylation), occur at virtually identical reso-
nance in HF-SCWPs from all examined strains of Ba and Bc.
(TIF)
S8 Fig. Comparison of the 1H-13C HSQC anomeric regions of Bc HF-SCWPs from: (A) Bc
G9241; (B) Bc CA (Cameroon). The spectra are virtually superimposable, with the exception
of "new" anomeric signals from residues J and K in the Bc CA sample. Additional heterogene-
ity of residue B (residue B00) is also observed in Bc CA (and Bc CI) SCWPs. The α- and β- labels
designate the anomeric signals arising from the reducing-end GlcNAc residue of the respective
HF-SCWPs.
(TIF)
S9 Fig. Partial 1H-13C HMBC spectrum showing the trans-glycosidic connectivities
between J1!B003 and G1!B03 for the borodeuteride reduced-HF-SCWP from great ape
isolate Bc CA. These 3-bond connectivities prove the linkage of residue J to the 3-position of
residue B00, and of residue G to 3-position of B0.
(TIF)
S10 Fig. 1H-13C HSQC and 1H-13C H2BC spectral regions demonstrating features of the
new J and K residue spin systems, residues unique to the Bc great ape strain isolates. Panel
A, HSQC, and panel B, H2BC of the Bc CA red-HF-SCWPs.
(TIF)
S11 Fig. Linkage (methylation) analysis of HF-SCWPs from Bc G9241 and Bc CA (Camer-
oon). (A) Total ion chromatogram (TIC) of the neutral sugar PMAA derivatives from Bc
G9241 SCWP; (B) TIC of neutral sugar PMAAs from Bc CA HF-SCWP; (C) electron impact
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mass spectrum of the 3-linked Gal PMAA derivative from the Bc CA sample. The GC-MS
analysis of the neutral sugar PMAA derivatives demonstrates the presence of 3-linked Gal in
the "great ape" strain HF-SCWP, but not in Bc G9241. Only the great ape derived SCWPs
(from Bc CA and Bc CI) yield this derivative, which arises from the K1!J3 disaccharide sub-
stituent unique to these strains. The results of this chemical analysis (1.86 residues/PS for Bc
CA) are in close agreement with NMR signal integration (refer to Table 3). The 4-linked-Glc
derivative arises from traces of a contaminating α-glucan, most of which is removed by SEC
(see S12 Fig).
(TIF)
S12 Fig. Purification and molecular size estimation of the HF-SCWP isolated from differ-
ent Bacillus strains. SCWP were released from cell walls by treatment with hydrofluoric acid,
dialyzed, then chromatographed on a Superose-12 FPLC size exclusion column with compari-
son to commercially available α1!6 linked dextrans. A, great ape isolate B. cereus CA (Camer-
oon) (Kav 0.410). B, B. anthracis Sterne 34F2 (Kav 0.433). C, type strain B. cereus ATCC14579
(Kav 0.337; calculated mass 20,020 Da). The HF-SCWP from the great ape isolates Bc CA/CI
and Bc strains all elute at approximately the same location, between the 25 kDa and 10.5 kDa
dextran standards, having calculated mass of approx. 12,000 Da for Bc CA (Kav 0.410) and for
Bc G9241 (Kav 0.411, not shown). The elution profiles of human isolates Bc G9241 and Bc
03BB87 HF-SCWPs are all essentially identical to that of Bc CA ([27], see Forsberg et al., 2011,
Supplement Data for human Bc isolate analysis). Interestingly, the structurally unrelated B.
cereus type strain ATCC14579 HF-SCWP elutes slightly after the 25 kDa dextran standard sug-
gesting a mass around 20 kDa. The Bacillus SCWP isolates, in particular those from Ba and
pathogenic Bc, contain variable amounts of a high molecular weight glucan which elutes at the
void volume (Vo) (panels A and B). Glycosyl composition (GC-MS) and NMR analysis
(COSY, TOCSY, HSQC) indicated that this void volume polysaccharide is composed exclu-
sively of glucose in predominately α1!4 linkage. This glucan may correspond to a glycogen
polysaccharide previously reported in certain B. anthacis and related pathogenic Bacillus
strains. Proteins (i.e., aromatic compounds, Abs 280 nm) also elute at this void region. Column
total inclusion volume = (Vi). In addition to the 35–40 kDa dextran profile, the elution posi-
tions of the 25 kDa and 10.5 kDa dextrans are indicated by arrows (1 = 35–40 kDa, Kav 0.239;
2 = 25 kDa, Kav 0.299; 3 = 10.5 kDa, Kav 0.433).
(TIF)
Acknowledgments
The authors thank Teresa G. Abshire (USAMRIID/Frederick, MD, USA) for providing Bc
CDC684 cell materials, John Glushka (CCRC/UGA, GA, USA) for assistance with NMR analy-
ses, and Jarad Schiffer (CDC, Atlanta, GA, USA) for his help in interpreting the immunologi-
cal data. The findings and conclusions in this report are those of the author(s) and do not
necessarily represent the views of the Centers for Disease Control and Prevention. Patent
Pending–University of Georgia Research Foundation, Inc. and US Centers for Disease Control
and Prevention.
Author Contributions
Conceptualization: Russell W. Carlson, Lennart S. Forsberg, Elmar L. Kannenberg, Conrad P.
Quinn.
Formal analysis: Nazia Kamal, Jhuma Ganguly, Elke Saile, Silke R. Klee, Alex Hoffmaster,
Lennart S. Forsberg.
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
PLOS ONE | https://doi.org/10.1371/journal.pone.0183115 August 23, 2017 28 / 31
Funding acquisition: Russell W. Carlson, Conrad P. Quinn.
Investigation: Nazia Kamal, Jhuma Ganguly, Elke Saile, Silke R. Klee, Alex Hoffmaster, Len-
nart S. Forsberg.
Methodology: Nazia Kamal, Jhuma Ganguly, Elke Saile, Silke R. Klee, Alex Hoffmaster, Len-
nart S. Forsberg, Elmar L. Kannenberg.
Project administration: Russell W. Carlson, Conrad P. Quinn.
Resources: Elke Saile, Silke R. Klee, Alex Hoffmaster, Lennart S. Forsberg, Elmar L. Kannen-
berg, Conrad P. Quinn.
Supervision: Nazia Kamal, Elke Saile, Silke R. Klee, Alex Hoffmaster, Russell W. Carlson, Len-
nart S. Forsberg, Elmar L. Kannenberg, Conrad P. Quinn.
Validation: Nazia Kamal, Lennart S. Forsberg, Elmar L. Kannenberg, Conrad P. Quinn.
Visualization: Nazia Kamal, Lennart S. Forsberg, Elmar L. Kannenberg.
Writing – original draft: Nazia Kamal, Lennart S. Forsberg, Elmar L. Kannenberg, Conrad P.
Quinn.
Writing – review & editing: Elke Saile, Lennart S. Forsberg, Conrad P. Quinn.
References
1. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biolog-
ical terrorism agents. Emerg Infect Dis. 2002; 8(2): 225–230. https://doi.org/10.3201/eid0802.010164
PMID: 11897082
2. Keim P, Smith KL, Keys C, Takahashi H, Kurata T, Kaufmann A. Molecular investigation of the Aum
Shinrikyo anthrax release in Kameido, Japan. J Clin Microbiol. 2001; 39(12): 4566–4567. https://doi.
org/10.1128/JCM.39.12.4566-4567.2001 PMID: 11724885
3. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related
inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001; 7(6): 933–
944. https://doi.org/10.3201/eid0706.010604 PMID: 11747719
4. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, et al. Investigation of bio-
terrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002; 8
(10):1019–1028. https://doi.org/10.3201/eid0810.020353 PMID: 12396909
5. Courtney B, Sherman S, Penn M. Federal Legal Preparedness Tools for Facilitating Medical Counter-
measure Use during Public Health Emergencies. The J Law, Medicine & Ethics: a journal of the Ameri-
can Society of Law, Medicine & Ethics. 2013; 41 (Suppl 1): 22–27.
6. Russell PK, Gronvall GK. U.S. medical countermeasure development since 2001: a long way yet to go.
Biosecurity and bioterrorism: biodefense strategy, practice, and science. 2012; 10(1): 66–76.
7. Henderson I, Duggleby CJ, Turnbull PC. Differentiation of Bacillus anthracis from other Bacillus cereus
group bacteria with the PCR. Int J Syst Bacteriol. 1994; 44(1): 99–105. https://doi.org/10.1099/
00207713-44-1-99 PMID: 8123566
8. Helgason E, Okstad OA, Caugant DA, Johansen HA, Fouet A, Mock M, et al. Bacillus anthracis, Bacil-
lus cereus, and Bacillus thuringiensis—one species on the basis of genetic evidence. Appl Environ
Microbiol. 2000; 66(6): 2627–2630. PMID: 10831447
9. Ash C, Farrow JA, Dorsch M, Stackebrandt E, Collins MD. Comparative analysis of Bacillus anthracis,
Bacillus cereus, and related species on the basis of reverse transcriptase sequencing of 16S rRNA. Int
J Syst Bacteriol. 1991; 41(3): 343–346. https://doi.org/10.1099/00207713-41-3-343 PMID: 1715736
10. Rasko DA, Altherr MR, Han CS, Ravel J. Genomics of the Bacillus cereus group of organisms. FEMS
Microbiol Rev. 2005; 29(2): 303–329. https://doi.org/10.1016/j.femsre.2004.12.005 PMID: 15808746
11. Leoff C, Saile E, Sue D, Wilkins P, Quinn CP, Carlson RW, et al. Cell Wall Carbohydrate Compositions
of Strains from the Bacillus cereus Group of Species Correlate with Phylogenetic Relatedness. J Bac-
teriol. 2008; 190(1): 112–121. https://doi.org/10.1128/JB.01292-07 PMID: 17981984
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
PLOS ONE | https://doi.org/10.1371/journal.pone.0183115 August 23, 2017 29 / 31
12. Choudhury B, Leoff C, Saile E, Wilkins P, Quinn CP, Kannenberg EL, et al. The structure of the major
cell wall polysaccharide of Bacillus anthracis is species-specific. J Biol Chem. 2006; 281(38): 27932–
27941. https://doi.org/10.1074/jbc.M605768200 PMID: 16870610
13. Leoff C, Choudhury B, Saile E, Quinn CP, Carlson RW, Kannenberg EL. Structural Elucidation of the
Nonclassical Secondary Cell Wall Polysaccharide from Bacillus cereus ATCC 10987. J Biol Chem.
2008; 283(44): 29812–29821. https://doi.org/10.1074/jbc.M803234200 PMID: 18757856
14. Leoff C, Saile E, Rauvolfova J, Quinn CP, Hoffmaster AR, Zhong W, et al. Secondary cell wall polysac-
charides of Bacillus anthracis are antigens that contain specific epitopes which cross-react with three
pathogenic Bacillus cereus strains that caused severe disease, and other epitopes common to all the
Bacillus cereus strains tested. Glycobiology. 2009; 19(6): 665–673. https://doi.org/10.1093/glycob/
cwp036 PMID: 19270075
15. Klee SR, Ozel M, Appel B, Boesch C, Ellerbrok H, Jacob D, et al. Characterization of Bacillus anthracis-
Like Bacteria Isolated from Wild Great Apes from Cote d’Ivoire and Cameroon. J Bacteriol. 2006; 188
(15): 5333–5344. https://doi.org/10.1128/JB.00303-06 PMID: 16855222
16. Klee SR, Brzuszkiewicz EB, Nattermann H, Bru¨ggemann H, Dupke S, Wollherr A, et al. The Genome of
a Bacillus Isolate Causing Anthrax in Chimpanzees Combines Chromosomal Properties of B. cereus
with B. anthracis Virulence Plasmids. PLoS ONE. 2010; 5(7): e10986. https://doi.org/10.1371/journal.
pone.0010986 PMID: 20634886
17. Antonation KS, Grutzmacher K, Dupke S, Mabon P, Zimmermann F, Lankester F, et al. Bacillus cereus
Biovar Anthracis Causing Anthrax in Sub-Saharan Africa-Chromosomal Monophyly and Broad Geo-
graphic Distribution. PLoS Negl Trop Dis. 2016; 10(9): e0004923. https://doi.org/10.1371/journal.pntd.
0004923 PMID: 27607836
18. De BK, Bragg SL, Sanden GN, Wilson KE, Diem LA, Marston CK, et al. A two-component direct fluores-
cent-antibody assay for rapid identification of Bacillus anthracis. Emerg Infect Dis. 2002; 8(10): 1060–
1065. https://doi.org/10.3201/eid0810.020392 PMID: 12396916
19. Ezzell JW, Abshire TG, Little SF, Lidgerding BC, Brown C. Identification of Bacillus anthracis by using
monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide. J Clin Microbiol. 1990;
28(2): 223–231. PMID: 2107201
20. Sterne M. The effects of different carbon dioxide concentrations on the growth of virulent antrax strains.
Pathogenicity and immunity tests on guinea pigs and sheep with anthrax variants derived from virulent
strains. Ond J Vet Sci An Ind. 1937; 9: 16–52.
21. Cataldi A, Labruyere E, Mock M. Construction and characterization of a protective antigen-deficient
Bacillus anthracis strain. Mol Microbiol. 1990; 4(7): 1111–1117. PMID: 2122174
22. Hoffmaster AR, Hill KK, Gee JE, Marston CK, De BK, Popovic T, et al. Characterization of Bacillus
cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and
harbor B. anthracis virulence genes. J Clin Microbiol. 2006; 44(9): 3352–3360. https://doi.org/10.1128/
JCM.00561-06 PMID: 16954272
23. Lawrence TFW. Studies on aerobic spore-bearing and non-pathogenic bacteria: spore-bearing bacteria
in milk. J Bacteriol. 1916; 1: 277–320. PMID: 16558697
24. Hoffmaster AR, Ravel J, Rasko DA, Chapman GD, Chute MD, Marston CK, et al. Identification of
anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc
Natl Acad Sci U S A. 2004; 101(22): 8449–8454. https://doi.org/10.1073/pnas.0402414101 PMID:
15155910
25. Brown WC. Rapid methods for extracting autolysins from Bacillus subtilis. Appl Microbiol. 1973; 25:
295–300. PMID: 4632855
26. Forsberg LS, Abshire TG, Friedlander A, Quinn CP, Kannenberg EL, Carlson RW. Localization and
structural analysis of a conserved pyruvylated epitope in Bacillus anthracis secondary cell wall polysac-
charides and characterization of the galactose-deficient wall polysaccharide from avirulent B. anthracis
CDC 684. Glycobiology. 2012; 22(8): 1103–1117. https://doi.org/10.1093/glycob/cws080 PMID:
22556058
27. Forsberg LS, Choudhury B, Leoff C, Marston CK, Hoffmaster AR, Saile E, et al. Secondary cell wall
polysaccharides from Bacillus cereus strains G9241, 03BB87 and 03BB102 causing fatal pneumonia
share similar glycosyl structures with the polysaccharides from Bacillus anthracis. Glycobiology. 2011;
21(7): 934–948. https://doi.org/10.1093/glycob/cwr026 PMID: 21421577
28. Zanetta JP, Timmerman P, Leroy Y. Gas-liquid chromatography of the heptafluorobutyrate derivatives
of the O-methyl-glycosides on capillary columns: a method for the quantitative determination of the
monosaccharide composition of glycoproteins and glycolipids. Glycobiology. 1999; 9(3): 255–266.
PMID: 10024663
29. Ciucanu I, Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr
Res. 1984; 131: 209–217.
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
PLOS ONE | https://doi.org/10.1371/journal.pone.0183115 August 23, 2017 30 / 31
30. Forsberg LS, Carlson RW. Structural Characterization of the Primary O-antigenic Polysaccharide of the
Rhizobium leguminosarum 3841 Lipopolysaccharide and Identification of a New 3-Acetimidoylamino-3-
deoxyhexuronic Acid Glycosyl Component. J Biol Chem. 2008; 283(23): 16037–16050. https://doi.org/
10.1074/jbc.M709615200 PMID: 18387959
31. Forsberg LS, Noel KD, Box J, Carlson RW. Genetic Locus and Structural Characterization of the Bio-
chemical Defect in the O-Antigenic Polysaccharide of the Symbiotically Deficient Rhizobium etli Mutant,
CE166: REPLACEMENT OF N-ACETYLQUINOVOSAMINE WITH ITS HEXOSYL-4-ULOSE PRE-
CURSOR. J Biol Chem. 2003; 278(51): 51347–51359. https://doi.org/10.1074/jbc.M309016200 PMID:
14551189
32. York WS, Darvill AG, McNeil M, Stevenson TT, Albersheim P. Isolation and characterization of plant
cell walls and cell wall components. Methods Enzymol. 1985; 118: 3–40.
33. Gerwig GJ, Kamerling JP, Vliegenthart JFG. Determination of the absolute configuration of monosac-
charides in complex carbohydrates by capillary G.L.C. Carbohydr Res. 1979; 77: 1–7.
34. Piantini U, So¨rensen OW, Ernst RR. Multiple quantum filters for elucidating NMR coupling networks. J
Am Chem Soc. 1982; 104: 6800–6801.
35. Bax A, Davis DG. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy.
J Magn Reson. 1985; 65: 355–360.
36. Macura S, Huang Y, Suter D, Ernst RR. Two-dimensional chemical exchange and cross-relaxation
spectroscopy of coupled nuclear spins. J Magn Reson. 1981; 43: 259–281.
37. Davis AL, Laue ED, Keeler J, Moskau D, Lohman J. Absorption mode two-dimensional NMR spectra
recorded using pulse field gradients. J Magn Reson. 1991; 94: 637–644.
38. Petersen BO, Vinogradov E, Kay W, Wu¨rtz P, Nyberg NT, Duus JØ, et al. H2BC: a new technique for
NMR analysis of complex carbohydrates. Carbohydr Res. 2006; 341(4): 550–556. https://doi.org/10.
1016/j.carres.2005.11.020 PMID: 16406276
39. Carbohydrate Builder: Woods Group. (2005–2017) GLYCAM Web. Complex Carbohydrate Research
Center UoG, Athens, GA. Available from: http://glycam.org.
40. Kirschner KN, Yongye AB, Tschampel SM, Gonzalez-Outeirino J, Daniels CR, Foley BL, et al. GLY-
CAM06: A Generalizable Biomolecular Force Field. Carbohydrates. J Comput Chem. 2008; 29(4): 622–
655. https://doi.org/10.1002/jcc.20820 PMID: 17849372
41. Li H, Soroka SD, Taylor TH Jr., Stamey KL, Stinson KW, Freeman AE, et al. Standardized, mathemati-
cal model-based and validated in vitro analysis of anthrax lethal toxin neutralization. J Immunol Meth-
ods. 2008; 333(1–2): 89–106. https://doi.org/10.1016/j.jim.2008.01.007 PMID: 18304568
42. Candela T, Maes E, Gare´naux E, Rombouts Y, Krzewinski F, Gohar M, et al. Environmental and Bio-
film-dependent Changes in a Bacillus cereus Secondary Cell Wall Polysaccharide. J Biol Chem. 2011;
286(36): 31250–31262. https://doi.org/10.1074/jbc.M111.249821 PMID: 21784857
43. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin
Microbiol Rev. 2005; 18(3): 521–540. https://doi.org/10.1128/CMR.18.3.521-540.2005 PMID:
16020688
44. Niederweis M, Danilchanka O, Huff J, Hoffmann C, Engelhardt H. Mycobacterial outer membranes: in
search of proteins. TIM. 2010; 18(3): 109–116.
45. Wilson JW, Schurr MJ, LeBlanc CL, Ramamurthy R, Buchanan KL, Nickerson CA. Mechanisms of bac-
terial pathogenicity. Postgrad Med J. 2002; 78(918): 216–224. https://doi.org/10.1136/pmj.78.918.216
PMID: 11930024
46. Weintraub A. Immunology of bacterial polysaccharide antigens. Carbohydr Res. 2003; 338(23): 2539–
2547. PMID: 14670715
47. Gevorkian G, Segura E, Acero G, Palma JP, Espitia C, Manoutcharian K, et al. Peptide mimotopes of
Mycobacterium tuberculosis carbohydrate immunodeterminants. Biochem J. 2005; 387(Pt 2): 411–417.
https://doi.org/10.1042/BJ20041139 PMID: 15560754
48. Verez-Bencomo V, Fernandez-Santana V, Hardy E, Toledo ME, Rodriguez MC, Heynngnezz L, et al. A
synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science (New
York, NY. 2004; 305(5683): 522–555.
49. Oppenheimer SB, Alvarez M, Nnoli J. Carbohydrate-based experimental therapeutics for cancer, HIV/
AIDS and other diseases. Acta Histochem. 2008; 110(1): 6–13. https://doi.org/10.1016/j.acthis.2007.
08.003 PMID: 17963823
50. Verdaguer V, Walsh TJ, Hope W, Cortez KJ. Galactomannan antigen detection in the diagnosis of inva-
sive aspergillosis. Expert Rev Mol Diagn. 2007; 7(1): 21–32. https://doi.org/10.1586/14737159.7.1.21
PMID: 17187481
51. Goossens PL. Animal models of human anthrax: the Quest for the Holy Grail. Mol Aspects Med. 2009;
30(6): 467–480. https://doi.org/10.1016/j.mam.2009.07.005 PMID: 19665473
Structure and immunoreactivity of Bacillus species secondary cell wall polysaccharides
PLOS ONE | https://doi.org/10.1371/journal.pone.0183115 August 23, 2017 31 / 31
